Georgia State University

ScholarWorks @ Georgia State University
Biology Dissertations

Department of Biology

10-29-2008

The Impact of Neonatal Inflammatory Insult on Adult
Somatosensory Processing: The Role of the Descending
Nociceptive Circuit
Jamie L. LaPrairie

Follow this and additional works at: https://scholarworks.gsu.edu/biology_diss
Part of the Biology Commons

Recommended Citation
LaPrairie, Jamie L., "The Impact of Neonatal Inflammatory Insult on Adult Somatosensory Processing:
The Role of the Descending Nociceptive Circuit." Dissertation, Georgia State University, 2008.
doi: https://doi.org/10.57709/1063878

This Dissertation is brought to you for free and open access by the Department of Biology at ScholarWorks @
Georgia State University. It has been accepted for inclusion in Biology Dissertations by an authorized administrator
of ScholarWorks @ Georgia State University. For more information, please contact scholarworks@gsu.edu.

THE IMPACT OF NEONATAL INFLAMMATORY INSULT ON ADULT
SOMATOSENSORY PROCESSING: THE ROLE OF THE DESCENDING
NOCICEPTIVE CIRCUIT

JAMIE L. LAPRAIRIE

THE IMPACT OF NEONATAL INFLAMMATORY INSULT ON ADULT
SOMATOSENSORY PROCESSING: THE ROLE OF THE DESCENDING
NOCICEPTIVE CIRCUIT

by

JAMIE L. LAPRAIRIE

Under the Direction of Anne Z. Murphy, Ph.D.
ABSTRACT
The neonatal period represents a critical window of increased neurodevelopmental
plasticity in the immature nervous system. Unlike other sensory modalities, which
require appropriate stimulation for proper development, maturation of nociceptive
circuitry in neonates typically occurs in the absence of noxious stimulation. Premature
infants, however, are routinely exposed to multiple invasive medical procedures during
neonatal intensive care treatment, which are largely performed in the absence of
anesthetics or analgesics. To date, it is largely unknown how exposure to early noxious
insult during this time of increased plasticity alters the development of the CNS and
influences future nociceptive responses. As previous studies examining the impact of
neonatal inflammatory insult on adult nociceptive responses have been conducted
primarily in males, the potential adverse effects in females are unknown. Furthermore,
the biological mechanisms underlying neonatal insult-induced deficits in nociceptive
processing have yet to be elucidated. Therefore, this dissertation addressed the

following questions: (1) Does neonatal inflammatory insult differentially alter male and
female baseline somatosensory thresholds and response to re-inflammation in
adulthood?; (2) Are neonatal inflammation-induced deficits in nociceptive
responsiveness mediated by a potentiation in endogenous opioid tone?; and (3) Does
pre-emptive morphine analgesia attenuate the behavioral consequences of neonatal
inflammatory insult? Collectively, these studies will provide valuable information about
the long-term consequences of neonatal noxious stimulation in males and females,
which may lead to improved understanding and prevention of the lasting effects of
repeated invasive interventions in premature infants in the NICU.
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CHAPTER ONE

The Impact Of Neonatal Noxious Stimulation On Developing
Nociceptive Circuits-Introductory Overview

Submitted for Publication as a Review in Frontiers in Neuroscience
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1.1 The Impact Of Neonatal Noxious Stimulation On Developing Nociceptive
Circuits

Over the last several decades, the relative contribution of early life events to individual
disease susceptibility has been explored extensively. Only fairly recently, however, has
it become evident that abnormal or excessive nociceptive activity experienced
neonatally may permanently alter the normal development of the CNS and influence
future responses to somatosensory input. Given the significant rise in the number of
premature infants receiving high-technology intensive care over the last ten years, expreterm neonates may be exceedingly vulnerable to the long-term effects of repeated
invasive interventions. The present review summarizes available clinical and laboratory
findings on the lasting impact of exposure to noxious stimulation during early
development, with a focus on the structural and functional alterations in nociceptive
circuits.

1.2 Premature Birth

Overview
Premature birth, defined as birth prior to 37 weeks gestation, occurs at alarmingly high
rates worldwide. According to the World Health Organization, 16.5% of all infants are
born premature, with over 500,000 preterm babies born each year in the United States
alone (Martin et al., 2006). Indeed, the rates of premature births in the United States
have been escalating steadily to nearly 35% of all live births within the last two decades
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(Martin et al., 2006). While the underlying causes of prematurity are diverse and not
completely understood, several factors are known to contribute to the increased
prevalence of preterm births. Assisted reproduction, which often produces multi-fetal
pregnancies (twins, triplets, etc.), is one of the most significant risk factors, with nearly
40% of all multiples born premature (Martin et al., 2006). Moreover, tobacco, alcohol
and illicit drug use during pregnancy contribute to a heightened risk of premature
delivery (Shiono et al., 1995). Although nearly 50% of all premature births have no
known etiology, high maternal blood pressure, diabetes and obesity are also
contributing factors (Mathews and MacDorman, 2006). Finally, there is an increasing
prevalence of deliberately induced premature deliveries and caesarean sections due to
maternal or infant distress, and physician convenience.
During the last 25 years, advances in perinatal care have substantially increased the
survival of infants born extremely premature. As part of these life-saving interventions,
preterm neonates are routinely exposed to numerous noxious and invasive procedures
in the Neonatal Intensive Care Unit (NICU), which are frequently accompanied by local
inflammation and tissue damage lasting for several hours to days (Anand, 1998).
Intrinsic to their care in the NICU, preterm infants undergo more than 300 noxious
procedures per week including repeated heel lances, circumcision, endotracheal
intubation, surgery, and respiratory and gastric suctioning (Barker and Rutter, 1995,
Simons et al., 2003). Mounting evidence indicates that nociceptive circuitry is both intact
and functional during late gestation, and that premature infants are indeed capable of
mounting developmentally specific and distinct responses to noxious and non-noxious
stimuli (Anand and Carr, 1989, Giannakoulopoulos et al., 1999). Furthermore, recent
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studies report cortical activation in response to acute noxious stimulation in preterm
neonates at 25 weeks, suggesting the potential for higher-level processing of pain
(Bartocci et al., 2006, Slater et al., 2006b). Thus, the lasting effect of these procedures
on the developing somatosensory nervous system is a subject of considerable
importance.

1.3 The Impact Of Neonatal Noxious Insult

Long-Term Effects of Early Noxious Insult on Developing Nociceptive Systems-Clinical
Studies
The neonatal period is a time of increased neurodevelopmental plasticity. Unlike other
sensory systems which require proper stimulation for appropriate development, the
maturation of nociceptive circuitry typically occurs in the absence of noxious stimuli
(Lidow, 2002, Fitzgerald, 2004). Accumulating clinical evidence in humans indicates that
exposure to invasive procedures during the neonatal period can lead to long-term
alterations in subsequent physiological and behavioral responses to innocuous and
noxious somatosensory stimulation (Porter et al., 1999, Anand and Scalzo, 2000,
Whitfield and Grunau, 2000, Grunau et al., 2005).
Early pioneering studies on the lasting impact of early life noxious stimulation in human
infants reported that heel lance elicits decreased facial and enhanced cardiovascular
responses in preterm infants with prior NICU experience compared to age matched fullterm infants (Johnston et al., 1996). Subsequent studies revealed that a higher
frequency of invasive procedures in preterm infants is significantly associated with
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dampened nociceptive responses at 32 weeks of age compared to controls (Grunau et
al., 2001). Moreover, decreased facial responsiveness to immunization at 4 and 8
months (Oberlander et al., 2000), and blunted nociceptive sensitivity have been
reported in 18 month old former preterm neonates compared to full term peers (Grunau
et al., 1994a). Former NICU toddlers are also rated by parents as less pain sensitive
compared to term-born controls, with a higher frequency of procedural pain exposure
associated with more dampened nociceptive responsiveness to noxious stimulation at
18 months of age (Grunau et al., 1994a).
In contrast to the reduced nociceptive responsiveness following acute neonatal noxious
stimulation, early surgery and tissue damage in infancy lead to prolonged sensitization
of nociceptive responses. Hypersensitivity to tissue damage is observed in human
infants, in that a decrease in sensory thresholds is observed for days or weeks in the
presence of local or deep visceral tissue injury (Andrews and Fitzgerald, 1999, Andrews
and Fitzgerald, 2002). Furthermore in premature infants, the withdrawal reflex threshold
in an area of local tissue damage following repeated heel lances is half the value of that
on the intact contralateral heel for several months following the initial insult (Fitzgerald
et al., 1988a, Fitzgerald et al., 1988b). Interestingly, this response is not restricted to the
site of injury, as former NICU infants also display secondary hyperalgesia in the intact,
contralateral limb (Andrews and Fitzgerald, 1994). Similarly, infants that experienced
surgery within the first three months of life display enhanced hypersensitivity to
subsequent surgery performed in the same dermatome that persists for more than one
year (Peters et al., 2005). This hypersensitivity is also not restricted to the site of tissue
damage, as neonates demonstrate greater sensitivity to mechanical stimulation both in
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the area of incision and on the contralateral side of the body following corrective
unilateral abdominal surgery (Andrews et al., 2002). Moreover, term-born males that
experienced un-anesthetized neonatal circumcision respond more intensely to routine
inoculation at 4-6 months in comparison to uncircumcised infants; this effect is partially
attenuated by pre-treatment with a local anesthetic (Taddio et al., 1995).
Interestingly, alterations in nociception do not appear to be transient in nature, whereby
both full- and preterm infants with prior NICU experience display an increased threshold
for acute thermal stimuli (i.e. decreased sensitivity), but enhanced perceptual
sensitization to a prolonged heat stimulus (i.e. hyper-sensitivity) up to 14 years of age
(Hermann et al., 2006). Former preterm adolescents also display significantly greater
tenderness in response to pressure (Buskila et al., 2003), are more prone to lasting
clinical somatization (Grunau et al., 1994b), and report earlier onset of pediatric
migraine (Maneyapanda and Venkatasubramanian, 2005) compared to full-term peers.
Indeed, 10-year old children with former NICU experience also rate pictures of medical
events as more intense than pictures of psychosocial pain events, unlike term-born
children (Grunau et al., 1998b).

Long-Term Effects of Early Noxious Insult on Developing Nociceptive SystemsExperimental Animal Studies
There is considerable parallel evidence in non-human animal models that neonatal
noxious stimulation induces persistent alterations in somatosensory structure and
function which last into adult life (Ruda et al., 2000, Torsney and Fitzgerald, 2003, Ren
et al., 2004). Data collected to date suggest, however, that the type of noxious
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stimulation (acute versus tonic) is critical to the long-term impact. Early pioneering
studies reported that persistent neonatal inflammation induced by unilateral intraplantar
application of Complete Freund’s adjuvant results in enhanced nociceptive sensitivity,
as well as increased primary afferent nerve fiber innervation of the spinal cord that
extend into adulthood (Ruda et al., 2000). Similarly, local hindpaw skin wounds induced
during the first week of life result in long-lasting cutaneous hypersensitivity, expanded
dorsal horn receptive fields, and profound sprouting of local sensory nerve terminals in
adulthood (Ruda et al., 2000, Torsney and Fitzgerald, 2003). This hyperinnervation is
associated with a long-lasting decrease in mechanical threshold in the wounded region,
as well as a substantial up-regulation of growth factors including NGF and BDNF
(Whitby and Ferguson, 1991, Constantinou et al., 1994, Reynolds and Fitzgerald,
1995). Finally, early life chronic intra-colonic irritation following repeated applications of
mustard oil results in lasting visceral hyperalgesia (Al-Chaer et al., 2000).
In contrast, a generalized decrease in nociceptive sensitivity as a consequence of acute
stimulation such as repetitive foot shock and intraplantar formalin injections has been
demonstrated (Shimada et al., 1990, Bhutta et al., 2001). Likewise, neonatal laparotomy
results in decreased nociceptive responses to tail-withdrawal and acidic acid abdominal
constriction tests compared to control subjects in adulthood (Sternberg et al., 2005).
Furthermore, a long-term global elevation of nociceptive thresholds in response to
noxious thermal and mechanical stimulation following short-lasting local neonatal
inflammation with intraplantar carrageenan has been reported (Ren et al., 2004). This
response is also associated with excessive hyperalgesia in the presence of on-going
inflammation following a subsequent inflammatory insult in adulthood (Ren et al., 2004).
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Together, these data suggest that early life exposure to acute versus persistent noxious
stimulation may differentially affect developing nociceptive circuitry, whereby producing
distinct long-term effects.
Interestingly, all of the previous studies examining the impact of neonatal inflammation
on adult somatosensory processing and dorsal horn physiology have been conducted
exclusively in males (Anand et al., 1999, Ruda et al., 2000, Ren et al., 2004). Therefore,
the lasting effects of early noxious insult in females are unknown. Furthermore, although
the aforementioned animal studies demonstrate a causal effect of noxious sensory
stimulation during the neonatal period on subsequent nociceptive sensitivity, the
mechanisms underlying these deleterious neonatal insult-induced deficits have yet to be
elucidated.

1.4 Sex Differences In Response to Neonatal Noxious Stimulation

Sex steroid hormones such as estrogens and androgens modulate prenatal and
postnatal functional development and have potent influences on pain thresholds in male
and female rats (Liu and Gintzler, 2000, Aloisi et al., 2003). Prenatally, males
experience a significant surge of testicular testosterone that is centrally aromatized to
estradiol and ultimately results in the masculinization of the male brain (Weisz and
Ward, 1980, Amateau et al., 2004, Balthazart and Ball, 2006, Cornil et al., 2006). In
females, the ovaries are quiescent and intracerebral estradiol remains low at birth
(Weisz and Ward, 1980, Amateau et al., 2004, Balthazart and Ball, 2006, Cornil et al.,
2006). Similar differences in hormone levels may also be present in peripheral tissues
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as well. Given that estrogens have been shown to exert neuromodulatory and
neuroprotective effects following acute and chronic central injuries, increased perinatal
central estradiol in males may contribute to lasting sexually dimorphic responses to
early life noxious stimulation (Garcia-Segura et al., 2001, Amateau et al., 2004, Maggi
et al., 2004).
Estrogen also influences the expression of a number of pro-inflammatory as well as pronociceptive agents that may contribute to sex differences in nociceptive responses. For
example, prostaglandins (which are pro-inflammatory) are released peripherally in
response to injury, and estrogen has been shown to modulate both prostaglandin and
COX-1 and COX-2 expression in peripheral tissues (Zhang et al., 1997). In adults,
estrogen also modulates vascular tone in a tissue specific manner (vasodilation,
vasoconstriction), which may lead to differences in inflammation-induced edema (Maggi
et al., 2004). Peripheral injury also results in increased BDNF that is thought to promote
neuronal survival and healing. As estrogen increases BDNF expression centrally, this
may also attenuate the adverse effect of peripheral injury (Allen and McCarson, 2005).
In addition, activational gonadal hormones can alter the processing of nociceptive
information. Sex-steroids influence endogenous opioid systems (Berglund et al., 1988,
Smith et al., 1998), as well as the activity of other neuromodulators involved in
nociceptive processing; including substance P, gamma-aminobutyric acid (GABA),
glutamate, dopamine, serotonin and norepinephrine (Smith, 1994, Duval et al., 1996).
Moreover, gonadal hormones have been shown to have a marked influence on estrous
cycle effects on nociceptive and analgesic sensitivity in rodents (Fillingim and Ness,
2000, Craft et al., 2004), as well as menstrual cycle variability in chronic pain conditions
9

such as migraine headache (MacGregor, 1997), temporomandibular disorders (Warren
and Fried, 2001), and fibromyalgia (Anderberg et al., 1998).
Thus, several mechanisms may contribute to a sexually dimorphic effect of neonatal
noxious insult, including sex differences in the neuroendocrine environment at the time
of injury and/or at the time of testing. While there are no reported sex differences in
response to early life noxious stimulation in premature infants, the aforementioned
studies suggest that the lasting impact of procedural pain experienced in the NICU may
indeed be sexually dimorphic. In addition, all of the previous experimental rodent
studies that have examined the lasting consequences of neonatal noxious insult on
developing nociceptive circuits have been conducted exclusively in males. Hence, the
inclusion of female subjects in future studies examining this topic is warranted, as
premature females may be at considerably increased risk for long-term consequences
of early life trauma.

1.5 Potential Mechanism Underlying The Neonatal Noxious Insult-Induced Deficits
In Nociceptive Responsiveness

While the impact of neonatal noxious stimulation on developing nociceptive circuitry and
subsequent pain processing and perception has been the focus of a significant amount
of research within the last decade, clinical and experimental studies have failed to
elucidate the mechanisms underlying the reported lasting alterations in nociceptive
responsiveness. Several candidate mechanisms have been proposed to account for the
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long-term alterations in nociceptive behavior following exposure to neonatal noxious
insult, including an elevation in basal endogenous opioid tone.
The modulation of nociception is mediated in part by a descending inhibitory pathway
that includes the midbrain periaqueductal gray (PAG), the brainstem rostral
ventromedial medulla (RVM) and the spinal cord dorsal horn (Basbaum and Fields,
1978, Basbaum and Fields, 1984). In adults, this circuit is activated in the presence of
persistent noxious stimulation, and functions to inhibit nociceptive transmission via
endogenous opioids (Dubner and Ren, 1999). At birth, however, descending inhibitory
controls are developmentally plastic and inherently vulnerable to noxious sensory
stimulation (Fitzgerald and Koltzenburg, 1986, Fitzgerald, 1991). Evidence that early life
trauma can shape the maturation of descending inhibitory circuits has previously been
reported in both human and non-human animal studies. Preterm infants exposed to
numerous interventions in the NICU display significantly altered descending inhibitory
responses to noxious thermal stimulation, as well as heightened cardiac reactivity
compared to both term-born and premature infants exposed to few noxious procedures
(Goffaux et al., 2008), suggesting that the central nervous system may adapt to early
noxious insult with a compensatory up-regulation of tonic endogenous opioid inhibition.
Similarly, tonic descending inhibition of dorsal horn neurons is substantially altered in
adult rats treated at birth with capsaicin (Cervero and Plenderleith, 1985). Nonnociceptive related perinatal manipulations, such as prenatal stress, prenatal ethanol
exposure and post-natal handling have been reported to affect opioid-mediated
processes in adulthood (Nelson et al., 1985, Nelson et al., 1986, Kinsley et al., 1988,
Pieretti et al., 1991). Finally, a deficit in descending inhibitory systems is implicated in
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several chronic pain conditions, including fibromyalgia (Henriksson, 1994, Julien et al.,
2005), irritable bowel syndrome (Wilder-Smith et al., 2004), and tension-type headache
(Pielsticker et al., 2005).
Therefore, the inherent developmental plasticity of the descending inhibitory circuit at
birth may have significant implications, as noxious sensory input experienced neonatally
may indeed alter the functional integrity of endogenous pain modulatory systems as an
adaptive response to early insult, whereby leading to lasting alterations in nociceptive
processing.

1.6 Effects Of Analgesia On Developing Nociceptive Circuitry

Despite the current knowledge that preterm infants are responsive to noxious
stimulation (Giannakoulopoulos et al., 1999, Smith et al., 2000, Vanhatalo and van
Nieuwenhuizen, 2000) and the accumulating evidence that invasive procedures can
have lasting effects on developing nociceptive circuitry, neonatal pain remains an
under-recognized and under-treated condition in the NICU (Porter et al., 1997, Kahn et
al., 1998, Simons et al., 2003). Indeed, many life-saving intensive care interventions are
performed in the absence of analgesics, (Johnston et al., 1997, Porter et al., 1997,
Kahn et al., 1998, Simons et al., 2003) as recent studies have reported that neonates
experience an average of 14 noxious procedures per day, with fewer than 35%
receiving appropriate analgesic therapy (Anand and Craig, 1996, Simons et al., 2003).
Accumulating data suggests that premature infants undergoing invasive procedures,
however, benefit from the use of opioid analgesics (Yaster and Deshpande, 1988,
12

Yaster et al., 1989, Fitzgerald, 1991, Anand and Hickey, 1992, Bhat et al., 1992). For
example, altered pain responses in former preterm neonates can be predicted by the
number of previous painful procedures and are normalized by the early use of morphine
as an analgesic (Grunau et al., 2001). In addition, post-operative morphine analgesia in
preterm and full-term infants reduces behavioral and hormonal stress responses
(Farrington et al., 1993, Bouwmeester et al., 2001, Bouwmeester et al., 2003) and is
associated with decreased mortality (Anand et al., 1987, Anand and Hickey, 1992).
Furthermore, 45 month-old children that experienced operations following pre-emptive
analgesia during early life respond to immunization pain in a similar manner as nonoperated age-matched controls (Peters et al., 2003). Lastly, long-term assessments of
formerly preterm children exposed to continuous morphine infusions during NICU care
indicate no adverse effects of morphine on intelligence, motor function, or behavior at 6
years of age (MacGregor et al., 1998).
Clearly, the aforementioned studies imply the importance of analgesic therapy for
neonates undergoing NICU and hospital treatment as a means to prevent lasting
alterations in nociceptive processing. Further studies examining the effects of preemptive analgesics in the NICU are challenging, however, as the humane care of
infants requires physicians to treat those perceived to be in distress. As such, the gaps
in our knowledge of the long-term risks and benefits of analgesic therapy in newborns
would greatly benefit from experimental animal models. Although there is significant
evidence that opioid analgesics are efficacious in neonatal rodents (Abbott and Guy,
1995), few studies have examined whether opioid analgesics can be used to prevent
the long-term sequelae associated with neonatal noxious insult (Sternberg et al., 2005).
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1.7 Dissertation Goals

The overall aim of this dissertation was to determine the impact of early life noxious
stimulation on developing nociceptive circuitry and somatosensory processing. Our
overarching hypothesis was that neonatal inflammatory insult produces lasting deficits
in nociceptive responsiveness mediated by specific neuroanatomical and
neurochemical alterations in endogenous pain modulatory systems, and that these
effects were differentially expressed in males and females. The dissertation research
presented herein tested this hypothesis via the following questions: (1) Does neonatal
inflammatory insult differentially alter male and female baseline somatosensory
thresholds and response to re-inflammation in adulthood? (2) Are the neonatal
inflammation-induced deficits in nociceptive responsiveness mediated by a potentiation
in endogenous opioid tone? (3) Does pre-emptive morphine analgesia attenuate the
behavioral consequences of neonatal inflammatory insult? Collectively, these studies
provide valuable information about the long-term consequences of neonatal noxious
stimulation in males and females, which may lead to improved understanding and
treatment of the lasting effects of repeated invasive interventions in premature infants in
the NICU.
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CHAPTER TWO
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2.1 Abstract

Premature infants are routinely exposed to invasive medical procedures during neonatal
intensive care treatment that are largely performed in the absence of anesthetics or
analgesics. Data collected to date suggest that exposure to early insult during this time
of increased plasticity alters the development of the CNS and influences future pain
responses. As previous studies examining the impact of neonatal injury on nociception
have been conducted primarily in males, the potential adverse effects on females is not
known. Therefore, the present studies were conducted to determine whether neonatal
injury differentially impacts male and female sensory thresholds in adulthood. A short
lasting inflammatory response was evoked in male and female rats on the day of birth
with an injection of carrageenan (CGN; 1% or 2%) into the right hind paw. Nociceptive
thresholds were assessed using a noxious thermal stimulus at both adolescence (P40)
and adulthood (P60). A more persistent inflammation was subsequently evoked in adult
rats with an intraplantar injection of Complete Freund’s adjuvant (CFA). Neonatally
injured females exhibited significantly greater hypoalgesia at P60, and displayed
enhanced inflammatory hyperalgesia following re-injury in adulthood compared to
neonatally injured males and controls. These results demonstrate that the long-term
adverse effects of neonatal injury are exacerbated in females, and may contribute to the
higher prevalence, severity and duration of pain syndromes noted in women compared
to men.
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2.2 Introduction

The neonatal period is a time of increased neurodevelopmental plasticity. Unlike other
sensory systems, which require proper stimulation for appropriate development,
maturation of nociceptive circuitry typically occurs in the absence of adequate stimuli
(Lidow, 2002, Fitzgerald, 2004). Premature infants, however, are routinely exposed to
invasive medical procedures during neonatal intensive care treatment (Anand, 1998,
Grunau et al., 2005, Peters et al., 2005). Hundreds of thousands of infants are born
premature each year, and as a result of major medical and technological advances in
neonatal care, infants born after 23 weeks’ gestation are routinely kept alive (Qiu,
2006). In order to increase their chances of survival these newborns experience an
average of 14 noxious procedures per day in the Neonatal Intensive Care Unit (NICU),
including heel lances, endotracheal intubation, respiratory and gastric suctioning, and
catheter insertion (Simons et al., 2003).
Recent evidence indicates that nociceptive circuitry is both intact and functional during
late gestation, and that premature infants are indeed responsive to noxious stimulation
(Bartocci et al., 2006, Slater et al., 2006a). Furthermore, growing clinical data suggests
that exposure to noxious stimulation in premature neonates can lead to long-term
alterations in subsequent physiological and behavioral responses to innocuous and
noxious somatosensory stimulation (Anand, 2000b, Whitfield and Grunau, 2000,
Grunau et al., 2005). Several studies report that former preterm infants exposed to
multiple invasive procedures during NICU care display dampened behavioral responses
and enhanced physiological responses to subsequent pain (Anand, 2000b, Oberlander
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et al., 2000, Whitfield and Grunau, 2000, Grunau et al., 2005). Parallel evidence in nonhuman animal models also suggests that neonatal noxious stimulation is associated
with long-term changes in somatosensory structure and function (Bhutta et al., 2001,
Lidow, 2002, Walker et al., 2003, Ren et al., 2004, Wang et al., 2004).
Previous studies examining the impact of neonatal inflammation on adult
somatosensory processing and dorsal horn physiology were conducted exclusively in
males (Ruda et al., 2000, Lidow, 2002, Ren et al., 2004). The neuroendocrine profile of
the newborn laboratory rat is sexually dimorphic such that in males, there is a significant
surge of testicular testosterone that is centrally aromatized to estrogen and ultimately
results in the masculinization of the male brain (Weisz and Ward, 1980, Amateau et al.,
2004, Balthazart and Ball, 2006, Cornil et al., 2006). In females, the ovaries are
quiescent and intracerebral estradiol remains low (Weisz and Ward, 1980, Amateau et
al., 2004, Balthazart and Ball, 2006, Cornil et al., 2006). Estrogens have been shown to
exert neuromodulatory and neuroprotective effects following acute and chronic central
injuries (Garcia-Segura et al., 2001, Maggi et al., 2004, Amantea et al., 2005).
Therefore, increased central levels of estrogen in males may attenuate the long-term
adverse effects of neonatal injury, whereas in females the consequences of neonatal
injury may be exacerbated. The aim of the current study was (1) to determine whether
neonatal inflammation differentially affects male and female sensory thresholds in
adulthood and (2) to test whether the impact of neonatal injury on inflammation-induced
hyperalgesia in adulthood is sexually dimorphic.
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2.3 Materials and Methods
Animals
Time-pregnant Sprague-Dawley rats were obtained on the 14th day of gestation (E14)
(Zivic Miller) and housed individually. Animals were maintained on a 12:12h light:dark
cycle, with food and water available ad libitum. On the day of birth (P0), sexing of the
pups was determined by examination of the anogenital distance. All litters were reared
identically, weaned at P21, and housed with same-sex littermates in groups of 2-3. All
experiments adhered to the guidelines of the Committee for Research and Ethical
Issues of IASP, and were approved by the Georgia State University Animal Care and
Use Committee.
Early Life Manipulations
Acute neonatal injury was induced by unilateral hindpaw injection of carrageenan (CGN;
1% or 2% soln dissolved in sterile in saline; 5ul volume; Sigma, St. Louis MO) into the
plantar surface of the right hindpaw within 12 hours of birth on P0, except for critical
period experiments where neonatal injury was induced on P8 or P14. This inflammatory
agent provides a well-established model of acute local inflammation that lasts for 12-72
hours (Lidow, 2002, Ren et al., 2004). Control animals received either an equivolume of
sterile saline into the right hindpaw or were “handled” in a similar manner and returned
to their home cage. All pups within a litter received the same neonatal treatment.
Maternal Behavior
Mother-pup interactions were observed for 1 hour following the neonatal injury, and
daily at 18:00 hours (1 hour prior to lights off) for 60 minutes from P0-P21. Maternal
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observations were conducted by both direct observations (in a manner so as not to
disrupt the dam) and by videotape for later offline analysis. Specific maternal behaviors
were recorded including pup licking/grooming, nursing posture (crouching), hovering
over pups, pup retrieval, nest construction, eating/drinking, exploring, inactive/napping
and self-grooming. Observations were conducted by an individual blind to the neonatal
group assignment.
Baseline Nociceptive Behavior
On P40 and P60, baseline paw withdrawal latencies (PWL) in response to a noxious
thermal stimulus were determined. Thermal testing was conducted using the Paw
Thermal Stimulator (UCSD, San Diego, California). In this test, animals were placed in a
clear plastic testing chamber on a glass surface and allowed to acclimate for a minimum
of 30 minutes prior to testing. A radiant beam of light beneath the glass base was
directed at the plantar surface of the each hindpaw and the withdrawal reflex latency
was electronically measured (in seconds). Intact male and cycling female rats were
tested separately. The average withdrawal latency of 3 trials was taken; all trials were
separated by a 5-minute inter-trial interval. Application of the thermal stimulus to either
paw was randomly determined. To avoid potential tissue damage, a 20-second
automatic termination of the heat stimulus was imposed if a paw withdrawal did not
occur. The testing apparatus was thoroughly cleaned between sessions. Body weight
and paw diameter for right and left hindpaws were measured prior to baseline testing on
P40 and P60.
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To characterize the estrous status of female rats, vaginal smears (using the saline
lavage technique) were taken daily beginning two weeks prior to testing and continuing
to the end of the experimental session. Proestrus was defined by the presence of
nucleated epithelial cells in >90% of the total cell population; estrus was defined by the
presence of cornified epithelial cells; diestrus-1 was defined as the presence of both
leukocytes and cornified epithelial cells; diestrus-2 was defined as the relative absence
of all cell types (Wang et al., 2006). All animals were smeared in the morning,
approximately 3-4 hours after lights on. Vaginal smears were conducted a minimum of
three hours prior to testing to minimize the potential effects of vaginal stimulationproduced analgesia (Komisaruk, 1977).
Nociceptive Behavior Following Re-Inflammation
Following baseline PWL determination at P60, animals received an injection of
Complete Freund’s adjuvant (CFA; 1:1 CFA:saline soln; 200ul; Sigma) into the plantar
surface of the right (neonatally injured) hindpaw. A separate group of animals received
intraplantar CFA into the left hindpaw. CFA was used for re-injury as neonatally-injured
animals may potentially develop antibodies against carrageenan (CGN), thereby limiting
its potency for use as an inflammatory agent. Twenty-four hours following CFA-induced
inflammation, paw diameter and PWLs were tested using the Paw Thermal Stimulator
as described above.
Drugs
The opioid antagonist naloxone hydrochloride (1 mg/kg; Sigma; St. Louis, MO) was
injected subcutaneously fifteen minutes prior to P60 testing. This dose of naloxone was
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chosen based on our previous observations demonstrating that 1 mg/kg of naloxone
was effective in reversing the effects of systemic morphine but had no effect on
nociceptive thresholds alone (Ji et al., 2006). Control animals received an equivolume of
saline.
Statistical Analysis
Data were expressed as raw withdrawal latencies or difference scores. A maximal PWL
of 20 seconds was used to prevent excessive tissue damage due to repeated
application of a noxious thermal stimulus. All values are reported as Mean + S.E.M.
Data were analyzed for significant main effects of neonatal treatment and sex using
ANOVA; p< 0.05 was considered statistically significant. Post-hoc tests using the
method of Sheffe were conducted as warranted to determine significant mean
differences. Where multiple comparisons were made, p values were adjusted
accordingly using the Bonferroni adjustment.

2.4 Results

Neonatal Injury Differentially Affects Male and Female Sensory Thresholds in Adulthood
Previous studies have reported that neonatally injured animals have significantly higher
sensory thresholds in adulthood (Lidow, 2002, Ren et al., 2004). These studies,
however, were conducted primarily in males. As central estradiol levels are significantly
elevated in males at this time point (Amateau et al., 2004), and estrogens have been
shown to confer neuroprotection (Garcia-Segura et al., 2001, Maggi et al., 2004,
Amantea et al., 2005), the present studies were conducted to determine if the long-term
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consequences of neonatal injury are exacerbated in females compared to males.
Intraplantar administration of carrageenan (CGN; 1% or 2%) on the day of birth resulted
in significantly longer paw withdrawal latencies (PWL) in comparison to control animals
at postnatal day 60 (P60). Thermal hypoalgesia was present in both the previously
injured (Figure 1A) and uninjured (Figure 1B) hindpaws. As shown in Figure 1, paw
withdrawal latency for the injured paw increased over 50% in injured animals (1% and
2% CGN) compared with saline and handled controls (p<.0001). Furthermore,
neonatally injured females displayed up to a 3 second longer latency in the injured paw
compared to neonatally injured males (p=.0078) (Figure 1A). This increased
hypoalgesia was also present in the uninjured paw (p<.0001) (Figure 1B). There were
no sex differences noted for saline and handled controls (p<.05).
Neonatal Injury Alters Sensory Thresholds at P40
The above studies demonstrate that neonatal injury produces decreased responses to
noxious thermal stimuli in adulthood and that this effect is exacerbated in females. We
next tested whether these sexually dimorphic effects were also evident during the periadolescent period (P40). At P40, neonatally injured male and female rats (1% and 2%
CGN) displayed significantly longer paw withdrawal latencies in response to a thermal
stimulus for the injured paw compared to saline and handled controls (p<.0001) (Figure
1C). Neonatal injury-induced hypoalgesia was also observed in the contralateral paw
(p<.0001) (Figure 1D). No significant main effect of sex was noted on any of the
withdrawal latencies, although there was a trend for the female contralateral paw
(p=.0737).
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Neonatal Injury Does Not Affect Body Weight, Paw Diameter, or Estrous Cycle
No significant differences in body weight or paw diameter (right and left hindpaws) were
noted in animals exposed to neonatal inflammation (1% and 2% CGN) compared to
control animals (saline and handled) at either P40 or P60 (Table 1). No significant
differences in estrous cycle were noted in neonatally injured females (1% and 2% CGN)
compared to control females (saline and handled) (i.e. all animals displayed normal four
day estrous cycles). As we have previously shown that estrous has no effect on
baseline pain sensitivity or CFA-induced hyperalgesia (Wang et al., 2006), females
were grouped together regardless of estrous stage.
Neonatal Injury Has No Impact On Maternal Care
Previous studies have shown that naturally-occurring variations in maternal behavior
can have a profound impact on a variety of developmental endpoints, including stress
responsiveness, reproductive behavior, pain, and learning and memory (Moore, 1992,
Sternberg, 1999, Liu et al., 2000, Johnston and Walker, 2003, Sternberg and Ridgway,
2003, Weaver et al., 2004). Given the profound and permanent changes induced by
alterations in maternal care, daily maternal observations were conducted to determine
whether neonatal inflammatory injury alters the display of maternal behavior. There
were no significant differences in maternal behavior between injured and non-injured
litters in the amount of time the dam spent on/with pups including crouching (nursing
posture), lying with pups, and pup retrieval (p=.2231) (Figure 3A). Similarly, no
differences were noted in the amount of time the dam spent off/without pups including
nesting, eating/drinking, exploring, napping, self-grooming (p=.2087) (Figure 3B); or in
the amount of time spent licking/grooming pups (p=.6939) (Figure 3C). This indicates
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that changes in adult sensory thresholds produced by neonatal injury are not due to
differences in maternal behavior directed at injured versus non-injured pups.
The Long-Term Consequences of Neonatal Injury are Critical Period Dependent
The next experiment was conducted to test whether the long-term consequences of
neonatal injury were dependent upon a critical period. Male and female rat pups
received a unilateral intraplantar injection of 1% CGN on P0, P8, or P14. Only 1% CGN
was used as no significant differences were noted in the previous studies following
administration of 1% versus 2% CGN. On P60, paw withdrawal latencies in response to
noxious thermal stimulation were determined. Animals that were neonatally injured on
P0 and P8 displayed significantly increased PWLs in both the injured (p=.0002) (Figure
4A) and uninjured (p=.0003) (Figure 4B) paws compared to animals that were injured on
P14. Furthermore, a significant effect of sex was noted for both paws in animals injured
on P0 and P8, with females displaying greater hypoalgesia compared to males
(p=.0068, p=.0014). No significant effect of intraplantar carrageenan or sex was noted
for animals injured on P14. These results suggest that the impact of neonatal injury is
dependent upon a sensitive period, and that noxious insult occurring outside of this
critical window does not permanently alter thermal sensory thresholds.
Neonatal Injury Enhances Hyperalgesia Following Re-Inflammation with CFA
The next series of experiments were conducted to test whether neonatally injured
animals respond differentially to a subsequent injury in adulthood. Following baseline
PWL determination at P60, animals received an injection of Complete Freund’s adjuvant
(CFA; 1:1 CFA:saline soln; 200ul; Sigma) into the plantar surface of either the right (P0
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injured) or left (P0 uninjured) hindpaw. Twenty-four hours following CFA-induced
inflammation, PWLs were tested in response to a noxious thermal stimulus.
The effect of neonatal injury on CFA induced hyperalgesia was quite profound. In
response to noxious thermal stimulation, the paw withdrawal latencies of CFA treated
adult control animals (handled and saline) decreased from approximately 8-9 seconds
at baseline to 4-5 seconds following intraplantar CFA (mean difference score of 5.5
sec), a typical hyperalgesic response (Wang et al., 2006). By contrast, latencies for
injured animals (1% CGN) decreased significantly from baseline PWLs of 10-12
seconds to 1-3 seconds (Figure 4A). This increased hyperalgesic response following
CFA re-injury was significantly greater in neonatally injured females compared to
neonatally injured males (mean difference scores of 12 for females versus 9 sec for
males). There was no significant effect of neonatal treatment on the degree of edema
produced by intraplantar CFA [F(3,118)=1.32, p=.2705].
Intraplantar CFA was administered in a separate group of animals into the left paw to
determine whether the increased hyperalgesia following re-injury would be observed
following adult re-inflammation of the neonatally uninjured paw. Similar to the previous
results, neonatally injured animals (1% CGN) displayed enhanced hyperalgesia
following intraplantar CFA compared to saline and handled controls (p=.0176) (Figure
5B). This effect was, again, exacerbated in females compared to males (p=.0108).
Neonatal Injury Induced Hypoalgesia is Attenuated By Systemic Naloxone
Neonatal injury results in significant long-term hypoalgesia that is present in both the
previously injured and uninjured paw. This bilateral response suggests a global, injury-

26

induced change in basal nociceptive sensitivity. The next series of experiments were
conducted to determine whether the observed hypoalgesia was a result of altered
endogenous opioid tone. At P60, animals received either systemic administration of the
opioid antagonist naloxone hydrochloride (NAL; 1 mg/kg) or equivolume saline (SAL)
fifteen minutes prior to testing. As shown in Figure 5, administration of NAL significantly
attenuated carrageenan-induced increases in paw withdrawal latencies, with no
significant differences noted between neonatally-injured/naloxone treated animals and
handled (p=.1576) or saline treated controls (p=.3665). Administration of naloxone
alone had no effect on paw withdrawal latencies for P0 saline or handled animals.

2.5 Discussion

Our principal findings are as follows: (1) neonatal inflammatory injury produces bilateral
basal hypoalgesia that is present in both adolescence and adulthood; (2) neonatally
injured animals display enhanced hyperalgesia in response to a subsequent injury in
adulthood; the effects of neonatal inflammatory injury on both baseline and re-injury
induced changes in nociception are sexually dimorphic, with significantly greater effects
present in females compared to males; (4) the long-term consequences of neonatal
injury are critical period dependent; (5) injury-induced hypoalgesia is reversed by
administration of the opioid antagonist naloxone.
Neonatal Inflammatory Injury Produces Thermal Hypoalgesia in Adulthood
Neonatal injury in rodents produces persistent and dramatic alterations in thermal
baseline sensory thresholds (Anand et al., 1999, Bhutta et al., 2001, Lidow, 2002, Ren
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et al., 2004). Previous studies have reported intraplantar carrageenan administered on
postnatal day 3 results in thermal and mechanical hypoalgesia in adult male rats (Lidow,
2002, Ren et al., 2004). Additionally, long-term visceral hypoalgesia has been reported
in animals exposed to carrageenan-induced inflammation as neonates (Wang et al.,
2004). Somatic hypoalgesia has also been reported following repeated intraplantar 10%
formalin injections in males (Bhutta et al., 2001). Here we demonstrate for the first time
that female rats also display thermal hypoalgesia in adulthood following neonatal hind
paw inflammation with carrageenan, and this hypoalgesia is significantly greater than
that observed in males. Thermal hypoalgesia was manifest at both P40 and P60 and
was present in both the injured and uninjured paw.
The global nature of the observed hypoalgesia following neonatal inflammatory injury
suggests that the underlying mechanisms are not manifested peripherally at the site of
injury, but rather may involve alterations in higher central regulatory systems. Our
finding that administration of the opioid antagonist naloxone reverses the injury-induced
hypoalgesia supports this theory. However, as there are currently no reliable and
reproducible methods for assessing nociception in P0 rat pups, we cannot conclusively
state that the observed hypoalgesia was due to the pain associated with inflammation.
Indeed, it is also likely that our P0 manipulations induced changes in the developing
hypothalamic-pituitary-adrenal axis. Nociception is one component in a broader context
of stress reactivity (Anand et al., 1999, Sternberg and Ridgway, 2003, Grunau et al.,
2005), and experimental studies have shown that exposure to early life stressors such
as repetitive neonatal handling can permanently increase nociceptive thresholds in adult
rats and decrease the behavioral and physiological responses to stress in adulthood
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(Pieretti et al., 1991, Coutinho et al., 2002, Sternberg and Ridgway, 2003). Interestingly,
a recent study demonstrating long-term thermal hypoalgesia in both sham operated and
surgically-manipulated mice suggests that the stress of the neonatal procedure, and not
necessarily the pain, contributes to the observed hypoalgesia (Sternberg et al., 2005).
Data from human preterm infants also suggests that neonatal exposure to noxious
stimuli may alter the responses to subsequent painful or stressful experiences. Expreterm infants exposed to four weeks of NICU care display reduced behavioral pain
behavior and enhanced cardiovascular responses following heel stick (Johnston and
Stevens, 1996). In addition, stressful conditions at birth are associated with increased
salivary cortisol in response to vaccination at 4 and 6 months of age (Peters et al.,
2005). Furthermore, premature infants at 8 and 18 months of age display increased
basal levels of stress hormones compared to their full-term counterparts (Grunau et al.,
2007).
Administration of the broad-spectrum opioid antagonist naloxone completely reversed
the hypoalgesia induced by neonatal injury, suggesting that the pain and stress
associated with our neonatal manipulations resulted in a potentiation in descending
endogenous opioid tone. Carrageenan-, formalin- and CFA-induced inflammation have
all been shown to profoundly enhance pro-dynorphin and pro-enkephalin biosynthesis in
spinal neurons in the dorsal horn (Iadarola et al., 1988, Noguchi et al., 1989).
Inflammation–induced changes in endogenous opioid peptide expression and release
have also been reported at several supraspinal sites, including the periaqueductal gray
(PAG); this increase in opioid peptide expression is associated with hypoalgesia
(Williams et al., 1995b). Pain-induced changes in opioid peptide expression are also
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paralleled by an increase in mRNA expression (Iadarola et al., 1988). In the present
study, naloxone was administered systemically; therefore, it is not known whether
neonatal injury-induced changes in opioid tone are peripherally or centrally mediated.
However, studies are currently underway using site-specific injections of naloxone to
further identify the loci for injury-induced changes in endogenous opioid tone.
Long-Term Effects of Neonatal Injury are Sexually Dimorphic
The neuroendocrine profile of a newborn rat pup is sexually dimorphic, such that males
have higher central levels of estradiol at birth compared to females, and similar
differences in hormone levels may also be present in peripheral tissues (Weisz and
Ward, 1980, Amateau et al., 2004, Balthazart and Ball, 2006, Cornil et al., 2006).
Estrogens have been reported to exert neuroprotective effects following acute and
chronic injuries in the adult CNS (Garcia-Segura et al., 2001, Maggi et al., 2004,
Amantea et al., 2005). In the present study, neonatal injury resulted in significantly
greater basal hypoalgesia at P60 in females in comparison to males. Indeed, the paw
withdrawal latency of females injured with 1% CGN was 3 seconds longer in both the
injured and uninjured paws compared to injured males. These results suggest that in
males, estrogens may be acting as a neuroprotectant in response to early life injury,
thereby leaving female rats with low to non-detectable levels of central estradiol
increasingly vulnerable to the effects of neonatal noxious insult. Female rats injured at
P14, when estradiol concentrations are comparable in males and females, displayed
equivalent levels of baseline hypoalgesia as injured males, further suggesting that sex
differences in the neonatal neuroendocrine environment contributed to the observed
sexually dimorphic impact of neonatal injury. A potential neuroprotective effect of
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androgens cannot be ruled out in the present study (Ramsden et al., 2003), and future
studies directed at manipulating the neonatal neuroendocrine environment, including
masculinizing females or castrating males, are necessary to more specifically implicate
gonadal hormones as the primary factor contributing to the observed sex differences in
the impact of neonatal inflammatory insult.
Estradiol has been shown to influence the expression of a number of pro-inflammatory
and pro-nociceptive agents. For example, prostaglandins (which are pro-inflammatory)
are released peripherally in response to injury, and estrogen has been shown to
modulate both prostaglandin and COX-1 and COX-2 expression in peripheral tissues
(Zhang et al., 1997). Furthermore, peripheral injury also results in increased BDNF that
is thought to promote neuronal survival and healing (Price et al., 2005). As estradiol
increases BDNF expression centrally, this may also attenuate the adverse effects of
peripheral injury (Allen and McCarson, 2005).
Re-Injury with CFA Produces Hyperalgesia and the Effect is Sexually Dimorphic
Following re-injury in adulthood with CFA, neonatally injured male and female rats
displayed significantly greater hyperalgesia than control animals. Furthermore,
neonatally injured females exhibited significantly greater hyperalgesia in the inflamed
paw than neonatally injured males, and male and female controls. This effect was
observed in both the neonatally injured and uninjured paws, and is consistent with
previous studies reporting long-term sensitization of afferent neurons and hyperalgesia
following neonatal insult (Reynolds and Fitzgerald, 1995, Anand et al., 1999, Al-Chaer
et al., 2000).
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This increased hyperalgesia following re-injury in adulthood appears disparate with the
observed basal hypoalgesia. Our preliminary anatomical studies, however, suggest that
neonatal inflammatory injury results in bilateral alterations in primary afferent innervation
of the dorsal horn (LaPrairie and Murphy, 2005), which may account for our observed
hyperalgesia. In particular, neonatal injury increases primary afferent innervation in the
L3-L5 spinal cord, as reflected by increased expression of both CGRP and substance P
immunoreactivity. As both CGRP and substance P are pro-nociceptive, this increase in
primary afferent innervation would be associated with a facilitated response to a noxious
stimulus. Our working hypothesis is that the pain associated with intraplantar CGN on
P0 results in a compensatory increase in descending inhibitory modulation as a
mechanism of pain management. An increase in descending opioid tone is supported
by our naloxone data, and would provide a direct mechanism for our observed
hypoalgesia at baseline testing. By contrast, reinjury in adulthood with the inflammatory
agent CFA results in an enhanced dorsal horn release of CGRP and/or substance P
due to increased primary afferent input. Increased release of these pro-nociceptive
peptides would be predicted to result in an enhanced hyperalgesic response. Increased
primary afferent innervation of the spinal cord may also drive an enhanced descending
facilitation in neonatally injured animals.

2.6 Chapter 2 Summary

Our findings clearly demonstrate that exposure to a single neonatal inflammatory insult
is associated with long-term decreases in nociceptive sensitivity that are significantly

32

exacerbated in females. The presence of a sex difference in the response to early insult
may contribute to the higher prevalence, severity, and duration of pain syndromes (i.e.
migraine, temporomandibular joint disorder, fibromyalgia and irritable bowel syndrome)
that are observed in women.
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2.7 Chapter 2 Figures

Figure 2.1 Neonatal injury differentially affects male and female sensory
thresholds in adulthood (P60) and during adolescence (P40). At P60, neonatally
injured animals display significantly longer withdrawal latencies compared to saline and
handled controls in response to a noxious thermal stimulus applied to the (A) right
(injured) paw [F(3,114)=41.76, p<.0001] and (B) (uninjured) paw [F(3,114)=34.68,
p<.0001]. There was also a significant main effect of sex with injured females displaying
significantly longer latencies in comparison to males: injured paw, F(1,114)=7.34,
p=.0078; uninjured paw, F(1,114)=11.31, p=.0011. Significant hypoalgesia was also
present at P40 in neonatally injured animals in both the (C) right (injured) paw
[F(3,114)=8.17, p< .0001] and (D) contralateral (uninjured) paw [F(3,114)=10.92,
p<.0001]. * denotes significant main effect compared to handled controls; # denotes a
significant main effect of sex.
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Figure 2.2. Neonatal Injury has no impact on maternal care. Neonatal injury had no
effect on the (A) duration the dam spent on/with her litter [F(3,19)=.783, p=.5507], (B)
amount of time the dam spent away from her litter [F(3,19)=.381, p=.7676], (C) duration
of maternal licking and grooming behavior [F(3,19)=.128, p=.9425]. N=3-7 litters per
group.
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Figure 2.3. The consequences of neonatal injury are critical period dependent.
Paw withdrawal latencies for the injured paw are significantly increased on P60 in
animals neonatally injured with 1% CGN on P0 and P8 compared to animals injured on
P14 [F(2,39)=10.97, p=.0002] . Neonatally injured females (P0 and P8) display
significantly longer PWLs compared to neonatally injured males [F(1,39)=3.85,
p=.0068]. (B) Similar results were noted for the uninjured paw [F(2,39)=9.94, p=.0003].
PWLs were significantly longer for neonatally injured females (P0 and P8) in
comparison to injured males (P0) [F(1,39)=7.09, p=.0014]. N=6-12 rats per group/per
sex. * denotes significant main effect of treatment; # denotes significant main effect of
sex.
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Figure 2.3 Continued
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Figure 2.4. Neonatal injury enhances hyperalgesia following re-inflammation with
CFA. Neonatally injured males and females (1% CGN) had significantly greater
difference scores (Bsln PWL – CFA PWL) compared to saline and handled control
animals in response to intraplantar CFA in adulthood. This effect was observed in both
the (A) right (P0 injured) paw [F(2,85)=43.54, p<.0001] and (B) left (P0 uninjured) paw
[F(2,27)=19.08, p<.0001]. Both effects were significantly exacerbated in neonatally
injured females compared to neonatally injured males [F(1,85)=3.96, p=.0499] and
[F(1,27)=7.50, p=.0108]. N=6-15 rats per group/per sex. * denotes significant main
effect of treatment; # denotes significant main effect of sex.
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Figure 2.5. Hypoalgesia induced by neonatal injury is significantly attenuated by
systemic naloxone. Neonatally injured males and females that received naloxone
(CGN/NAL) prior to testing at P60 had significantly lower PWLs than injured animals
that received saline control (CGN/SAL) [F(5,38)=52.07, p<.0001]. Administration of
naloxone to saline (SAL/NAL) or handled (HAN/NAL) controls had no effect on PWLs.
N=6-8 rats per group/per sex. * denotes significant main effect of treatment; # denotes
significant main effect of sex.
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Table 2.1. Average Body Weight and Average Paw Diameter. There is no significant
difference in the average body weight across neonatal treatment groups on P40 and
P60 in males and females. There is also no significant difference in the average paw
diameter of the right and left hind paws across neonatal groups on P40 and P60 in
males and females.

MALE
TREATMENT
HANDLED
SALINE
1% CGN
2% CGN

P40
WT
298.8
+36
297.6
+11
295.1
+10
297.5
+41

RP
4.88
+.32
4.76
+.29
4.83
+.15
4.84
+.30

FEMALE
P60

LP
4.74
+.27
4.76
+.36
4.82
+.15
4.77
+.17

WT
456.9
+38
443.2
+44
448.6
+24
462.8
+30

RP
5.55
+.27
5.48
+.21
5.57
+.14
5.60
+.28

40

P40
LP
5.52
+.28
5.49
+.21
5.57
+.14
5.60
+.28

WT
213.8
+10
209.7
+11
206.1
+10
214.2
+13

RP
4.39
+.20
4.45
+.14
4.33
+.21
4.40
+.23

P60
LP
4.46
+.21
4.36
+.16
4.32
+.20
4.35
+.19

WT
272.9
+19
265.7
+16
268.1
+12
267.3
+30

RP
4.67
+.41
4.71
+.38
4.61
+.12
4.59
+.15

LP
4.70
+.40
4.68
+.36
4.61
+.14
4.56
+.17

CHAPTER THREE

Neonatal Inflammatory Insult-Induced Hypoalgesia is Mediated by
Increased Central Endogenous Opioid Tone: Role of Beta-Endorphin
and Met/Leu-Enkephalin in the Periaqueductal Gray
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3.1 Abstract
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We have previously reported that neonatal intraplantar inflammation results in
significant long-term increases in nociceptive thresholds (hypoalgesia) in both male and
female rats. The mechanisms underlying these long-term deficits, however, have yet to
be elucidated. The present studies tested the hypothesis that the observed basal
hypoalgesia is due to an injury-induced increase in endogenous opioid tone. On the day
of birth, male and female Sprague Dawley rats received an intraplantar injection of the
inflammatory agent carrageenan (CGN; 1%). Control animals received an equivolume
of saline or were handled only. On postnatal day 60, paw withdrawal latencies to a
noxious thermal stimulus were determined. Systemic administration of the opioid
antagonist naloxone HCl, but not the peripherally-acting naloxone methiodide,
completely reversed the neonatal injury-induced hypoalgesia, suggesting altered
endogenous opioid tone. Subsequent behavioral and anatomical studies were
conducted to determine the loci for injury-induced effects and the opioid receptor
subtypes involved. Results from these studies demonstrated that neonatal inflammatory
injury results in a significant increase in beta-endorphin and met/leu-enkephalin
immunoreactivity in the PAG, as well as decreased mu- and delta- opioid receptor
expression. Microinjection of the selective antagonist CTOP into the PAG reversed the
injury-induced hypoalgesia. Together, the data presented herein constitute a compelling
case that early noxious insult produces significant long-term alterations in endogenous
descending inhibitory mechanisms, thereby profoundly impacting nociceptive
responsiveness.
3.2 Introduction
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The impact of neonatal noxious stimulation on developing nociceptive circuitry and
subsequent pain processing and perception has been the focus of a significant amount
of research within the last decade. Evidence from clinical and animal research studies
have reported that noxious stimulation experienced early in life can result in lasting
alterations in sensory processing (Grunau et al., 1994a; Anand et al., 1999; Ruda et al.,
2000; Lidow et al., 2001; Bhutta et al., 2002; Ren et al., 2004; LaPrairie and Murphy,
2007). In preterm infants, a higher frequency of invasive procedures is associated with
significantly dampened pain responses at 32 weeks of age (Grunau et al., 2001).
Moreover, premature neonates with NICU experience display decreased behavioral
responses to heel-lance and inoculation at 8 months (Johnston and Stevens, 1996;
Oberlander et al., 2000), and are rated by parents as less sensitive to pain compared
with full-term peers at 18 months of age (Grunau et al., 1994a; Grunau et al., 1994b).
Interestingly, alterations in nociception do not appear to be transient in nature, such that
both full- and preterm infants with prior NICU experience display increased thresholds
for acute thermal stimuli up to 14 years of age (Hermann et al., 2006).
Non-human animal studies have also reported that neonatal noxious stimulation
induces persistent alterations in somatosensory structure and function which last into
adulthood (Ruda et al., 2000; Torsney and Fitzgerald, 2003; Ren et al., 2004; LaPrairie
and Murphy, 2007). For example, our laboratory and others have established that
neonatal intraplantar inflammation induces significant hypoalgesia in both the previously
injured and uninjured paws in adulthood, as well as excessive hyperalgesia and
significant reductions in the rate of recovery following a subsequent insult (Ren et al.,
2004; LaPrairie and Murphy, 2007). A generalized decrease in nociceptive sensitivity as
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a consequence of repetitive foot shock and intraplantar formalin injections has also
been demonstrated (Shimada et al., 1990; Bhutta et al., 2001). To date, however, the
mechanisms underlying these neonatal injury-induced deficits in sensory thresholds
have yet to be elucidated.
Nociceptive information is modulated in part by a descending inhibitory pathway that
includes the midbrain periaqueductal gray (PAG), the brainstem rostral ventromedial
medulla (RVM) and the spinal cord dorsal horn. Anatomical and physiological studies
have shown that the PAG contains endogenous opioid peptides, as well as opioid
receptors (Spetea et al., 2002, Wang et al., 2002). Interestingly, while in rats the
anatomical connections for nociceptive modulation are present at birth, descending
inhibitory controls are functionally immature throughout the first three postnatal weeks
(Fitzgerald and Koltzenburg, 1986; Boucher et al., 1998). The delayed maturation of
descending inhibition may contribute to an increased vulnerability of the immature
somatosensory system to excessive afferent input, whereby exposure to noxious
stimulation during a critical window may alter the functional integrity of the endogenous
descending inhibitory system.
The objective of the present study was to determine whether the observed deficits in
nociceptive responsiveness are due to alterations in descending modulation. Behavioral
and anatomical studies were conducted to test our hypothesis that neonatal injuryinduced hypoalgesia is mediated by an increase in endogenous opioid tone resulting
from facilitated activation of descending nociceptive inhibitory pathways.
3.3 Materials and Methods
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Subjects
Time-pregnant Sprague-Dawley rats were obtained on the 14th day of gestation (E14)
(Zivic Miller) and housed individually. Animals were maintained on a 12:12h light:dark
cycle, with food and water available ad libitum. On the day of birth (P0), sexing of the
pups was determined by examination of the anogenital distance. All litters were reared
identically, weaned at P21, and housed with same-sex littermates in groups of 2-3. All
experiments were approved by the Georgia State University Animal Care and Use
Committee and were conducted in strict compliance with the guidelines for pain
research established by the International Association for the Study of Pain (IASP).
Early Life Manipulations
Acute neonatal injury was induced by unilateral hindpaw injection of carrageenan (CGN;
1% soln dissolved in sterile in saline; 5ul volume; Sigma, St. Louis MO) into the plantar
surface of the right hindpaw within 12 hours of birth on P0. This inflammatory agent
provides a well-established model of acute local inflammatory pain that lasts for 12-72
hours (LaPrairie and Murphy, 2007). Control animals received either an equivolume of
sterile saline into the right hindpaw or were “handled” in a similar manner and returned
to their home cage. All pups within a litter received the same neonatal treatment.
Nociceptive Behavior Testing
Thermal testing was conducted using the Paw Thermal Stimulator (UCSD, San Diego,
California). Briefly, animals were placed in a clear plastic testing chamber on a glass
surface and allowed to acclimate for a minimum of 30 minutes prior to testing. A radiant
beam of light was directed at the plantar surface of the each hindpaw or 1.5 inches from
the distal end of the tail, and the latency to withdrawal was electronically measured (in
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seconds) (Hargreaves et al., 1988). Intact male and cycling female rats were tested
separately. The average withdrawal latency of 3 trials was taken; all trials were
separated by a 5-minute inter-trial interval. Application of the thermal stimulus to either
paw was randomly determined. To avoid potential tissue damage, a 20-second
automatic termination of the heat stimulus was imposed if a paw or tail withdrawal did
not occur. The testing apparatus was thoroughly cleaned between sessions.
Systemic Injections
To determine whether neonatal injury-induced hypoalgesia was due to increased
endogenous opioid tone, naloxone HCl (1mg/kg s.c.; Sigma, St. Louis, MO) was
administered 10 minutes prior to paw withdrawal latency (PWL) determination on P60.
To test whether alterations in opioid tone were peripherally mediated, the peripherally
acting opioid antagonist, naloxone methiodide (1mg/kg s.c.; Sigma, St. Louis, MO), was
administered 15 minutes prior to determination of paw withdrawal latencies in
adulthood. All drugs were dissolved in physiological saline to desired concentration;
doses used in the present experiments were selected based on our previous studies (Ji
et al., 2006; LaPrairie and Murphy, 2007).
Intracerebroventricular and Intra-PAG Injections
Rats (P45-50) were anesthetized with a mixture of ketamine, xylazine and
acepromazine (50mg/kg, 10mg/kg, 1mg/kg; s.c.) and placed in a stereotaxic apparatus.
For intracerebroventricular injections (i.c.v.), a craniotomy was made dorsal to the
lateral ventricle and a stainless steel guide cannula (22G, C313G, PlasticOne Inc,
Roanoke, VA) was implanted at the following coordinates (mm) [Bregma: -1.0;
Mediolateral: 1.4; Dorsoventral: 3.6]. For PAG injections, cannula were implanted at the
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following coordinates (mm) [Lambda: +.50; Mediolateral: .65; Dorsoventral: 5.8].
Cannulae were flushed every other day with 1.0µl of saline over a 60 second period. On
P60, naloxone HCl was injected into the ventricle (i.c.v.: 1.0µg/2.0µl; PAG: .5µg/.5µl;
Sigma, St. Louis, MO) over a two-minute period. In subsequent experiments the
following opioid antagonists were administered: mu receptor antagonist CTOP (i.c.v.:
1µg/2µl and 10µg/2µl; PAG: .5µg/.5µl and 7.5µg/.5µl), the delta receptor antagonist
naltrindole (i.c.v.: 1µg/2µl and 10µg/2µl; PAG: .5µg/.5µl and 7.5µg/.5µl) and the kappa
receptor antagonist nor-BNI (i.c.v.: 10µg/2µl; PAG: 7.5µg/.5µl). All antagonists were gifts
from NIDA. Mu and delta receptor antagonists and doses were administered in random
order 15 minutes prior to behavioral testing. As nor-BNI is a permanent antagonist, all
animals received this antagonist last (Craft et al., 2001; Craft and McNiel, 2003). In
contrast to the mu and delta antagonists, nor-BNI was administered and testing followed
24 hours later (Craft et al., 2001). A minimum 72-hour washout period between all drugs
and doses was imposed. Paw withdrawal latencies in response to noxious thermal
stimulation were determined at 15, 30, 45, 60, 90 and 120 minutes post-injection.
Injection sites were determined by administration of Pontamine Sky Blue (2.0µl; Sigma
Aldrich, USA) at the completion of the experiment. Brains were removed, sectioned and
mounted onto slides; all injections sites were verified histologically. Only animals with
injections sites into the lateral ventricle (i.c.v. experiment) or into the ventrolateral PAG
(Bregma: -7.64 to -8.30) were used for further analysis.

Immunohistochemistry
Perfusion Fixation

47

At P60, neonatally manipulated animals were given a euthanizing dose of Nembutal
(160mg/kg; i.p.), and then perfused transcardially (descending aorta clamped) with
200ml of 0.9% sodium chloride containing 2% sodium nitrite as a vasodilator, followed
by 250ml of 4% paraformaldehyde in 0.1M phosphate buffer containing 2.5% acrolein
(Polysciences, Warrington PA). Following fixation, a final rinse with the sodium
chloride/sodium nitrite solution was used to remove residual acrolein from the animal.
Immediately after perfusion, the brains were removed and the tissue stored at 4°C in
30% sucrose solution until sectioned. The brains were cut into 30-µm coronal sections
with a Leica 2000R freezing microtome (Leica Microsystems, Wetler Germany) and
stored freely floating in cryoprotectant-antifreeze solution (Watson, 1986) at -20°C until
immunohistochemical processing.
Immunohistochemistry
A 1:6 series through the rostrocaudal axis of each brain was processed for
immunohistochemical localization of mu opioid receptor, beta-endorphin, metenkephalin or leu-enkephalin. Briefly, sections were removed from the cryoprotectantantifreeze solution, rinsed extensively in potassium phosphate-buffered saline, and then
reacted for 20 minutes in 1% sodium borohydride to remove excess aldehydes.
Sections were then incubated in primary antibody solution in KPBS containing 0.1%
Triton X for 1 hour at room temperature, followed by 48 hours at 4°C. Mu
immunoreactivity was identified using the polyclonal rabbit anti-MOR antibody at a
concentration of 1: 35,000 (Chemicon; Billerica, MA). Beta-endorphin immunoreactivity
was recognized using the polyclonal rabbit anti-beta-endorphin antibody at a
concentration of 1: 30,000 (Peninsula Labs; Torrance, CA). Met- and leu- enkephalin
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immunoreactivity were identified using the polyclonal rabbit anti-met-enkephalin and
anti-leu-enkephalin antibodies at concentrations of 1: 50,000 (Immunostar; Hudson, WI)
and 1: 200,000 (Immunostar; Hudson, WI), respectively. After rinsing in KPBS, the
tissue was incubated for 1 hour in biotinylated goat-anti-rabbit IgG (Jackson
Immunoresearch, West Grove PA; 1:200), rinsed again, and incubated for 1 hour in
avidin-biotin peroxidase complex (ABC Elite Kit, Vecor, Burlingame CA; 1:10). After
rinsing in KPBS and sodium acetate (0.175M; pH 6.5), antigens were visualized using
nickel sulfate-intensified 3,3’-diaminobenzidine solution containing 0.08% hydrogen
peroxide in sodium acetate buffer. The reaction product was terminated after 20-30
minutes by rinsing in sodium acetate buffer. Sections were mounted out of saline onto
gelatin-subbed slides, air dried overnight, dehydrated in a series of graded alcohols,
cleared in xylene, and coverslipped with Permount.
Densitometry
The PAG was divided into three representative rostrocaudal levels: (Rostral: Bregma 6.72 to -7.04; Mid: Bregma -7.30 to -8.00; Caudal: Bregma -8.30 to -8.80). Furthermore,
dosomedial and lateral/ventrolateral subdivisions of the PAG were analyzed for each
section. 12-bit grayscale images of each section were captured with a 2X, 4X and 20X
objective on a Nikon Eclipse E800 microscope using a Sensys digital camera
(Biovisions Technology; Exton, PA). Quantitative analysis of the tissue was performed
using IP Spectrum software (Scanalytics; Fairfax, VA). The lateral/ventrolateral PAG
was sampled three times and the average grayscale pixel value (ODU; optical density
units) was recorded. Measures were corrected for nonspecific binding by subtraction of
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background measures taken from areas lacking immunoreactivity adjacent to the
lateral/ventrolateral PAG.
Receptor Autoradiography
Neonatally manipulated male and female rats were sacrificed on P60 by rapid
decapitation. Brains were quickly removed, flash-frozen on dry ice and stored at -80°C.
Next, brains were sectioned at 20 µm thickness with a Leica CM3050S cryostat, and
immediately mounted onto Super-frost slides and stored at −80°C until the time of
assay. For radiographical processing, sections were allowed to thaw to room
temperature and then immersed in 0.1% paraformaldehyde for 2 minutes to optimize
tissue integrity. Sections then were rinsed in 50mM Tris-NaCl (pH 7.4) at room
temperature for 15 min followed by a 15-minute rinse in 50nM Tris (pH 7.4). Next, the
tissue sections were incubated for 60 minutes at room temperature in a solution of 50
mM Tris (pH 7.4) with 10 mM MgCl2 and 0.1% bovine serum albumin. 3nm [3H]Naltrindole (20 Ci/mmol; NIDA) was added to label delta receptor binding or 1nm [3H]DAMGO (56.8 Ci/mmol; Perkin Elmer/NEN, MA) was added to label mu receptor
binding. Following incubation, sections were washed 3 times at 10 minutes each in
50mM Tris-HCl (pH 7.4) with 10 mM MgCl2 at room temperature, followed by a final dip
in cold dH2O. Sections were allowed to air-dry overnight and were then apposed to
autoradiographic film with [3H]-microscale standards (Perkin-Elmer/NEN, MA) for 4
weeks. Film plates were processed using a FujiFilm BAS 5000. Autoradiographic [3H]receptor binding was quantified from film using MultiGuage software (FujiFilm, USA).
[3H]-standards were used to convert uncalibrated optical density to disintegrations per
minute (DPM). For analysis, the PAG was divided into 3 rostrocaudal levels as
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described above, and DPM were determined for the lateral/ventrolateral subdivision of
each level. A mean for each level (rostral, mid, caudal) for each animal was then
calculated.
Statistical Analysis and Data Presentation
All values are reported as Mean + S.E.M. For behavioral analysis, data are expressed
as raw withdrawal latencies. Data were analyzed for significant main effects of neonatal
treatment (handled, saline, 1% carrageenan) and sex (male, female) using ANOVA or
Repeated Measures ANOVA; p< 0.05 was considered statistically significant. Sheffe
Post-hoc tests were conducted to determine significant mean differences between
groups that were apriori specified. Where multiple comparisons were made, p values
were adjusted accordingly using the Bonferroni method. For anatomical analysis, data
are expressed either as optical density units (ODU; immunohistochemistry) or
disinigrations per minute (DPM; autoradiography). ANOVA was used to test for
significant main effects of neonatal treatment (handled, 1% carrageenan), sex (male,
female) and PAG level (rostral, mid, caudal); p<.05 was considered significant for all
analyses. For data presentation, a representative animal from each experimental group
was selected. Photomicrographs were generated using a Synsys digital camera
attached to a Nikon Eclipse E800 microscope. Images were captured with IP Spectrum
software and finalized in Adobe Photoshop 7.0. Alterations to the images were strictly
limited to enhancement of brightness and contrast.

3.4 Results
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Neonatal injury-induced hypoalgesia is reversed with systemic naloxone
To test the hypothesis that neonatal injury results in the release of endogenous opioids,
and that this upregulated opioid tone is maintained in adulthood, neonatally manipulated
male and female rats received a systemic injection of the broad-ban opioid antagonist
naloxone HCl or saline control 15 minutes prior to behavioral testing at P60. Neonatally
injured (1% CGN) animals that were administered saline in adulthood displayed
significantly increased paw withdrawal latencies compared to saline and handled control
animals (p<.05; Figure 1a). This injury-induced hypoalgesia was significantly
exacerbated in neonatally-injured females compared to males, as previously reported
(LaPrairie and Murphy, 2007). In contrast, neonatally injured males and females that
received systemic naloxone HCl on P60 displayed paw withdrawal latencies of
approximately 9-10 seconds, consistent with withdrawal latencies in uninjured control
animals (Figure 1a). Indeed, opioid receptor blockade by systemic naloxone completely
reversed the neonatal injury-induced thermal hypoalgesia. Together, these data suggest
that the long-term hypoalgesia observed in neonatally injured animals is due to altered
endogenous opioid tone.
Alterations in opioid tone are not peripherally mediated
Opioid receptors are present both centrally and peripherally (Hiller et al., 1994). To
determine whether the changes in opioid tone were restricted to the periphery, adult
animals were administered the peripherally acting opioid antagonist naloxone
methiodide prior to behavioral testing. Neonatally injured animals (1% CGN) that
received saline prior to testing displayed significantly increased paw withdrawal
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latencies compared to handled and saline controls (p<.05; Figure 1b). Again, neonatally
injured females displayed significantly increased latencies compared to injured males
(p<.05; Figure 1b). There were no significant differences in PWLs between neonatally
injured animals administered saline versus naloxone methiodide (Figure 1b), suggesting
that alterations in endogenous opioid tone are not peripherally mediated.
Injury-induced deficits in opioid tone are centrally mediated
To determine whether the injury-induced hypoalgesia is mediated by supraspinal
alterations in endogenous opioid tone, naloxone HCl was administered into the lateral
ventricle and paw withdrawal latencies were tested in response to noxious thermal
stimulation over a 120-minute period. Neonatally injured males and females displayed
significantly increased PWLs at baseline compared to handled and saline controls
(p<.05; Figure 1c). Following central administration of naloxone (1.0µg/2.0µl, i.c.v;
Sigma, St. Louis, MO), PWLs in neonatally injured animals significantly decreased and
were comparable to control levels at 30-minutes post-naloxone. Moreover, withdrawal
latencies in injured animals returned to pre-injection levels 120-minutes following
administration of naloxone. In contrast, intracerebroventricular administration of
naloxone at the dose used in the present experiment had no effect on withdrawal
latencies in handled and saline control animals (Figure 1c). The transient reversal of the
neonatal injury-induced hypoalgesia following central administration of naloxone HCl in
adulthood suggests that alterations in endogenous opioid tone are mediated
supraspinally.

Alterations in central opioid tone involve mu and delta opioid receptors
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We next tested whether the alterations in central opioid tone were receptor-specific by
administering mu, delta and kappa selective antagonists into the lateral ventricle prior to
behavioral testing. Central administration of the mu receptor antagonist CTOP
(10µg/2µl) significantly reduced PWLs in neonatally injured males and females to
control levels at 15 minutes and 30 minutes post-injection, respectively (p<.05; Figure
2a). CTOP also blocked the injury-induced hypoalgesia in adult males and females at a
lower dose (1µg/2µl; i.c.v.; p<.05; data not shown). The delta receptor antagonist
naltrindole (10µg/2µl) reversed the hypoalgesia in neonatally injured males at 15
minutes post-naltrindole, whereas injured females displayed a significant reduction in
withdrawal latencies at 15 minutes and reached control levels at 90 minutes following
the injection (p<.05; Figure 2b). In contrast, low dose naltrindole (1µg/2µl) did not
reduce PWLs to control levels in neonatally injured males or females (data not shown).
Following administration of nor-BNI (10µg/2µl; Figure 2c), neonatally injured animals
continued to display significantly increased PWLs compared to saline and handled
control animals over the entire 120-minute testing period (p<.05; Figure 2c). Together,
these results suggest that neonatal inflammation results in persistent changes in opioid
tone that are centrally mediated, and involve both the mu and delta opioid receptor.
Alterations in opioid tone are mediated within the PAG
The PAG is an essential substrate for endogenous pain management (Basbaum and
Fields, 1978; Fields et al., 1980; Dostrovsky et al., 1983; Basbaum and Fields, 1984;
Fields et al., 1991; Williams et al., 1995). To test the hypothesis that neonatal injuryinduced alterations in opioid tone were mediated within the PAG, we administered
naloxone HCl directly into the mid ventrolateral PAG (VL-PAG) prior to behavioral
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testing in neonatally injured and control animals. A representative PAG cannulation site
is shown in Figure 3a. Intra-PAG naloxone significantly reduced PWLs in neonatally
injured males and females at 15 minutes post-injection (p<.05; Figure 3b). The dose of
naloxone HCl used in this experiment had no effect on PWLs in saline and handled
control animals. The PAG contains mu, delta and kappa receptors (Mansour et al.,
1995a; Mansour et al., 1995b); therefore, to determine which opioid receptor subtypes
in the PAG contribute to alterations in opioid tone, we administered specific opioid
antagonists directly into the mid VL-PAG. Intra-PAG administration of the mu receptor
antagonist, CTOP, significantly reduced PWLs in males and females compared to
control levels at 30 minutes post-injection (p<.05; Figure 4a). Administration of
naltrindole into the PAG, significantly reversed the hypoalgesia in neonatally injured
females, where PWLs were comparable or below control levels by 15 minutes postinjection and continued throughout the 120-minute testing period (p<.05; Figure 4b).
Interestingly, intra-PAG naltrindole significantly attenuated the hypoalgesia in neonatally
injured males (i.e. PWLs decreased 1-2 seconds) (p<.05; Figure 4b), but did not
completely reduce PWLs to control levels. Not surprisingly based on our previous data,
administration of nor-BNI into the VL-PAG did not significantly reduce withdrawal
latencies in injured males or females (Figure 4c).
Injury-induced increase in beta-endorphin immunoreactivity in the PAG
The results from our above studies demonstrate that neonatal injury induces an
increase in central endogenous opioid tone that is mediated within the PAG and
involves both mu and delta opioid receptors. Therefore, the next series of experiments
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were conducted to determine whether changes in endogenous opioid peptide and/or
receptor expression within the PAG underlie our observed behavioral effects.
Beta-endorphin, an endogenous opioid neuropeptide that has the highest affinity for mu
opioid receptors, was significantly increased in the lateral/ventrolateral region of the mid
(p<.05; Figure 5d) and caudal (p<.05; Figure 5d) PAG in neonatally injured males and
females compared to handled controls. No significant differences were observed in this
region in the rostral PAG (Figure 5d). Moreover, no significant sex differences in betaendorphin expression were detected at any level of the PAG (Figure 5d). Figures 5a-5c
display representative examples of beta-endorphin immunoreactivity in the
lateral/ventral lateral region of the mid-PAG in a handled and carrageenan-injected
animal.
Increased met- and leu-enkephalin in PAG following neonatal injury
Immunohistochemical studies were also conducted to determine whether neonatal
injury altered the expression of met- and leu-enkephalin in the PAG; these endogenous
opioid peptides preferentially bind to delta opioid receptors. Neonatally injured males
and females displayed significantly increased met-enkephalin immunoreactivity in the
lateral/ventrolateral region of the mid (p<.05) and caudal (p<.05) levels of the PAG
compared to control animals (Figure 6e). A significant effect of sex was noted in the
lateral/ventrolateral region of the mid and caudal PAG, whereby injured females
displayed significantly more immunoreactive fibers compared to injured males (p<.05).
No significant differences in immunoreactivity were noted in the rostral level of the PAG
(Figures 6e).
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Similarly, neonatal inflammation resulted in significant increases in leu-enkephalin
immunoreactivity in PAG. Specifically, in the lateral/ventrolateral region injured animals
displayed significantly increased leu-enkephalin immunoreactive fibers compared to
handled controls in the rostral (p<.05), mid (p<.05) and caudal (p<.05) PAG (Figure 6f).
In contrast to met-enkephalin, no significant effects of sex on leu-enkephalin
immunoreactivity was present at any level of the PAG. Representative examples of metenkephalin and leu-enkephalin immunoreactivity at the mid level of the PAG in handled
and carrageenan-injected animals are shown in Figures 6a-6d.
Injury-induced decrease in MOR-immunoreactivity and receptor binding in the PAG
Our final series of experiments used immunohistochemistry to determine if neonatal
injury also resulted in changes in opioid receptor expression. Figures 7a-7c display
representative examples of MOR-ir in the lateral/ventrolateral region of the mid-PAG in
a handled and carrageenan-injected animal.
Neonatally injured animals displayed reduced mu opioid receptor immunoreactivity
(MOR-ir) in the lateral/ventrolateral PAG in both the mid (p<.05) and caudal (p<.05)
levels compared to handled control animals (Figure 7d). In contrast, no significant
differences in MOR-ir were noted in the rostral PAG (Figure 7d). Furthermore, no
significant effect of sex on MOR-ir was observed at any level of the PAG in contrast to
our previous studies (Loyd and Murphy, 2008). However, in the present study females
were not divided by stage of estrous.
Neonatally injured animals also displayed reduced lateral/ventrolateral MOR binding in
the rostral (p<.05), mid (p<.05) and caudal (p<.05) levels of the PAG compared to
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handled controls (Figure 8e). A representative example of MOR binding at the mid level
of the PAG in a handled and carrageenan-injected male is shown in Figures 8a and 8b.
No significant effect of sex on MOR binding was observed at any level or subdivision of
the PAG.
Injury-induced decrease in DOR receptor binding in the PAG
A significant decrease in DOR binding was also observed at the mid level of the
lateral/ventrolateral PAG in neonatally injured females compared to all other groups
(p<.05; Figure 8c-8d, 8f). The sexually dimorphic expression of DOR binding in injured
animals is consistent with our behavioral effects following intra-PAG administration of
the delta opioid antagonist naltrindole (Figure 4b). No significant effects of neonatal
treatment or sex on delta opioid receptor binding were noted in the lateral/ventrolateral
area of the rostral and caudal levels of the PAG (Figure 8f).

3.5 Discussion

Our principle finding is that neonatal injury-induced hypoalgesia is reversed by systemic
administration of naloxone HCl. The peripherally acting naloxone methiodide had no
effect, while intracerebroventricular administration did, suggesting that injury-induced
changes in opioid tone are centrally mediated. Parallel anatomical and behavioral
experiments demonstrated that neonatal injury-induced alterations in opioid tone are
mediated within the PAG, and involve up-regulation of the endogenous opioids betaendorphin and met/leu-enkephalin, along with a concomitant decrease in mu and delta
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opioid receptors. These studies, together, provide a biological mechanism for the
hypoalgesia observed following neonatal injury.
Neonatal inflammation up-regulates endogenous opioid tone
In the present study, administration of the broad-spectrum opioid antagonist naloxone
HCl completely reversed the hypoalgesia induced by neonatal inflammatory injury,
suggesting that our neonatal manipulations resulted in a potentiation in endogenous
opioid tone. It is well established that descending inhibitory pathways modulate
nociceptive input and are activated in the presence of persistent pain in adulthood
(Dubner and Ren, 1999). At birth, however, descending inhibitory controls are
functionally immature (Fitzgerald, 1991), such that while the projections from the
brainstem to the dorsal horn are present anatomically, electrical stimulation of the
dorsolateral funiculus does not inhibit noxious-stimulus evoked activity in dorsal horn
neurons until postnatal day 10 in the rat (Fitzgerald and Koltzenburg, 1986; Boucher et
al., 1998). These early studies examining the physiological characteristics of the
descending inhibitory pathway utilized a mild noxious stimulus (pinch). In the present
studies a stronger nociceptive stimulus was used, which may have been more
successful in activating the descending inhibitory circuit as a way of modulating the
“pain”. Certainly, previous studies in both human and rodents suggest that early life
trauma can shape the maturation of descending inhibitory circuits. For example, preterm
infants exposed to numerous interventions in the NICU display significantly altered
inhibitory responses compared to both term-born and premature infants exposed to few
noxious procedures, as indicated by reduced counterirritation-induced analgesia
triggered using a cold pressor test (Goffaux et al., 2008). This suggests that inhibitory
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circuits are very plastic in terms of increased or decreased afferent drive. Taken
together with the present study, it appears that the central nervous system may adapt to
early noxious insult with a compensatory up-regulation of tonic endogenous opioid
inhibition.
Alterations in endogenous opioid tone are centrally, not peripherally, mediated
There is considerable evidence that the functional activity of central endogenous opioid
systems in adults is enhanced following noxious stimulation. In dorsal horn spinal
neurons, pro-dynorphin and pro-enkephalin biosynthesis is up-regulated in response to
carrageenan-, formalin- and CFA-induced inflammation (Iadarola et al., 1988; Noguchi
et al., 1989). Inflammation–induced changes in endogenous opioid peptide expression
and release have also been reported at several supraspinal sites, including the
periaqueductal gray (PAG) (Williams et al., 1995). Noxious stimulation-induced
changes in opioid peptide expression are also paralleled by an increase in mRNA
expression (Iadarola et al., 1988).
The periaqueductal gray (PAG), along with descending projections to the rostral
ventromedial medulla (RVM) and the spinal cord dorsal horn, constitute a primary
anatomical circuit involved in the descending modulation of pain and opioid analgesia.
Here we report that site-specific administration of naloxone HCl into the ventrolateral
PAG significantly reduced the persistent basal hypoalgesia associated with neonatal
inflammation, suggesting that opioidergic systems are persistently and functionally
altered in the PAG in response to neonatal inflammation. The PAG is rich in nerve
terminals and fibers containing endogenous opioids (Reichling et al., 1988), and opioid
receptors are localized throughout the rostral-caudal axis of the PAG, with the highest
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level of expression in the mid to caudal ventrolateral PAG (Mansour et al., 1995b; Wang
and Wessendorf, 2002). In the present study, we cannot exclude the involvement of
additional loci including the RVM and spinal cord dorsal horn, as they are modulated by
PAG activity and are also rich in opioid-containing nociceptive neurons (Mansour et al.,
1995a; Mansour et al., 1995b; Budai and Fields, 1998). Indeed, changes in opioid tone
induced by neontal injury are probably also evident in these regions.
Neonatal inflammation-induced anatomical alterations in endogenous opioidergic
systems in the PAG
In the present study, a significant increase in beta-endorphin peptide expression was
observed in the PAG of animals that were neonatally injured compared to controls. We
also demonstrated that neonatal inflammation resulted in a significant increase in metand leu-enkephalin immunoreactivity in the lateral/ventrolateral region of the mid and
caudal PAG. Interestingly, a significantly greater increase in met-enkephalin was
observed in neonatally injured females compared to injured males, and may provide the
biological basis for the dimorphic response to neonatal injury observed in males and
females. No significant sex difference in met-enkephalin immunoreactivity was present
at baseline, indicating that sex differences in met-enkephalin were injury-induced.
Although not investigated in the present study, endomorphins also play an important
role in the modulation of descending controls, and possess partial agonist properties at
mu-receptor sites in the PAG (Zadina et al., 1997; Horvath, 2000; Mizoguchi et al.,
2001). Therefore, their contribution to alterations in mu-receptor mediated alterations in
endogenous opioid tone cannot be ruled out.
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It is notable that alterations in the two opioidergic systems were very well correlated
across similar regions and levels of the PAG, thus suggesting that beta-endorphin and
enkephalin systems are acting in parallel in response to neonatal inflammation and
nociception. In addition to changes in opioid peptide expression, we also showed both
immunohistochemically and autoradiographically a significant decrease in mu and delta
opioid receptor expression in the PAG in neonatally injured animals compared to
controls.
Thus, neonatal inflammatory insult induces a central up-regulation of endogenous
opioid ligands paralleled by a compensatory down-regulation of cognate opioid
receptors in the PAG. Similar findings have been reported in rodent models, where
increased brain and spinal cord immunoreactive beta-endorphin, met-enkephalin and
dynorphin is observed, as well as decreased opioid receptor binding following
inflammatory insults in adult animals (Morris, 1993; Spetea et al., 2002) (Cesselin et al.,
1980; Millan et al., 1986a; Millan et al., 1986b; Spetea et al., 2002).
Alternative mechanisms underlying the persistent hypoalgesia in animals subjected to
neonatal inflammatory insult
Although the results of the present study strongly suggest that persistent alterations in
baseline nociceptive thresholds associated with neonatal inflammatory insult are
mediated by a central increase in endogenous opioid tone, additional mechanisms may
also contribute to our observed results. Noxious neonatal experiences lead not only to
decreased nociceptive sensitivity in adulthood, but also to significant alterations in the
behavioral and neuroendocrine responses to stress (Bernardi et al., 1986; Anand et al.,
1999; Bhutta et al., 2001; Schellinck et al., 2003; Sternberg and Ridgway, 2003;
62

Sternberg et al., 2005). Blunted emotionality, decreased anxiety, and reduced basal and
stress induced plasma corticotropin releasing factor (CRF) and adrenocorticotropin
hormone (ACTH) are displayed in adult rats following short-lasting, local inflammation
experienced during the first week of life (Bhutta et al., 2001; Anseloni et al., 2005).
Premature infants with extensive NICU care also exhibit low basal levels of stress
hormones at 3 months of age compared to their full-term counterparts (Grunau et al.,
2007). Recent studies have demonstrated increased serotonergic (5HT) receptor
expression in the PAG following early life adverse experience (Anseloni et al., 2005). As
stimulation of 5-HT receptors in the PAG produces reduced anxiety and global
hypoalgesia in rodents (Jenck et al., 1990; Kishimoto et al., 2001; Griffiths and Lovick,
2002; Graeff, 2004), this midbrain region may be a critical site involved in the regulation
of both anxiety and descending nociceptive inhibition (Bandler and Shipley, 1994;
Behbehani, 1995).
In summary, alterations in the developing hypothalamic-pituitary-adrenal axis may also
contribute to the long-term basal hypoalgesia observed following neonatal injury.
Indeed, neonatal inflammatory insult may result in a generalized reduction in reactivity
to aversive environmental stimuli due to parallel alterations in supraspinal nociceptive
and stress modulatory circuits (Ren et al., 2004; Anseloni et al., 2005).

3.7

Chapter 3 Summary

Our findings clearly demonstrate that the profound elevation of nociceptive thresholds
following neonatal inflammation reflects an experience-induced facilitation in
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descending nociceptive pathways. The dynamic physiological and anatomical
modification and modulation of opioidergic systems in the PAG is likely an adaptive
response to early trauma. Clinically, alterations in descending inhibitory controls may
have important implications, as the long-term impact of chronically elevated opioidergic
tone in vulnerable preterm infants is currently unknown.
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3.7 Chapter 3 Figures

Figure 3.1. Systemic and ICV naloxone HCl significantly attenuated the
hypoalgesia in neonatally injured animals, whereas naloxone methiodide had no
effect. (A) Neonatally injured males and females that received naloxone (CGN/NAL)
prior to testing at P60 had significantly lower PWLs than injured animals that received
saline control (CGN/SAL) [F(5,46)=32.56, p<.05]. Administration of naloxone to saline
(SAL/NAL) or handled (HAN/NAL) controls had no effect on PWLs. (B) Administration of
naloxone methiodide to neonatally injured (CGN/NAL-M) males and females prior to
testing at P60 had no significant effect on PWLs compared to injured animals that
received saline control (CGN/SAL). A significant main effect of treatment was noted in
that neonatally injured animals (CGN/NAL-M and CGN/SAL) displayed significantly
higher PWLs compared to saline (SAL/NAL-M and SAL/SAL) and handled (HAN/NAL-M
and HAN/SAL) controls [F(5,35)=176.61, p<.05]. (C) A significant effect of time post
naloxone by neonatal treatment was noted following ICV administration of naloxone
HCl, whereby neonatally injured males () and females () displayed significantly
reduced PWLs during the 120 minutes post-naloxone compared to handled and saline
controls [F(12,132)=15.87, p<.05]. Administration of naloxone to saline or handled
controls had no effect on PWLs. N=6-8 rats per group/per sex. * denotes significant
main effect of treatment; # denotes significant main effect of sex.
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Figure 3.1 Continued
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Figure 3.2. Specific opioid antagonist ICV administration. (A) A significant effect of
time by neonatal treatment effect was observed following ICV administration of the mu
receptor antagonist, CTOP, whereby neonatally injured males () and females ()
displayed significantly reduced PWLs during the 120-minute period compared handled
and saline control animals [F(12,108)=9.21, p<.05]. Administration of CTOP to saline or
handled controls had no effect on PWLs. (B) A significant effect of time post-naltrindole
(delta antagonist) by neonatal treatment was indicated following ICV administration,
whereby neonatally injured males () and females () displayed significantly reduced
PWLs during the testing period compared to controls [F(12,102)=.0009, p<.05].
Administration of naltrindole to control animals had no effect on PWLs. (C) No
significant effect of ICV administration of the kappa antagonist nor-BNI on PWLs was
noted in neonatally injured animals or controls. A significant main effect of neonatal
treatment was indicated, whereby neonatally injured animals displayed significantly
elevated PWLs compared to saline and handled control animals [F(2,14)=326.61,
p<.05). N=6-8 rats per group/per sex.
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Figure 3.2 Continued
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Figure 3.3. Intra-PAG naloxone significantly attenuated the persistent hypoalgesia
following neonatal inflammatory insult. (A) A photomicrograph of a representative
intra-PAG cannulation site in an adult rat (4X). (B) A significant effect of time postnaloxone by neonatal treatment was indicated following intra-PAG naloxone, whereby
neonatally injured males () and females () displayed significantly reduced PWLs
throughout the 120-minute testing period in comparison to saline and handled control
animals [F(12,144)=8.95, p<.05]. Intra-PAG naloxone had no effect on PWLs in control
animals. N=6-8 rats per group/per sex.
69

Figure 3.4. Specific opioid antagonist intra-PAG administration. (A) Intra-PAG
CTOP administration resulted in a significant effect of time post-CTOP by neonatal
treatment, whereby neonatally injured males () and females () displayed significantly
reduced PWLs during the 120-minute testing period compared to handled and saline
controls [F(12,144)=13.593, p<.05]. (B) Intra-PAG naltrindole produced a significant
effect of time post-naltrindole by neonatal treatment by sex, whereby neonatally injured
females () displayed significantly reduced PWLs during the 120-minute testing period
in comparison to neonatally injured males and handled and saline controls
[F(12,144)=2.92, p<.05]. N=6-8 rats per group/per sex. (C) Administration of nor-BNI
into the PAG had no significant effect on PWLs in neonatally injured or control animals.
A significant main effect of treatment was noted, whereby neonatally injured animals
(males-/ females-) displayed significantly increased PWLs compared to controls
[F(2,42)=474.25, p<.05]. Neonatally injured females also displayed significantly
increased PWLs compared to injured males [F(2,42)=13.65, p<.05]. N=6-8 rats per
group/per sex.
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Figure 3.4 Continued
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Figure 3.5. Neonatal injury results in a significant increase in beta-endorphin
immunoreactivity in the PAG. Photomicrograph depicting representative examples of
beta-endorphin-ir in the lateral/ventrolateral PAG in adult rats following neonatal
treatment; (A) handled; (4X), (B) handled; (20X); (C) 1% carrageenan; (20X). (D)
Neonatally injured (CGN) males and females display a significant increase in betaendorphin immunoreactivity in the lateral/ventrolateral region of the PAG in the (D) mid
level [F(1,16)=4.62, p<.05; and the (F) caudal level [F(1,16)=6.57, p<.05] compared to
handled control animals. N=6-8 rats per group/per sex. * denotes significant main effect
of treatment.
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Figure 3.6. Neonatal injury results in a significant increase in met- and leuenkephalin immunoreactivity in the PAG. Photomicrograph depicting representative
examples of met-enkephalin-ir in the PAG in adult rats following neonatal treatment; (A)
handled; (10X), (B) 1% carrageenan; (10X). Photomicrograph depicting representative
examples of leu-enkephalin-ir in the PAG in adult rats following neonatal treatment; (C)
handled; (10X), (D) 1% carrageenan; (10X). (E) Neonatally injured animals (CGN)
display a significant increase in met-enkephalin immunoreactivity in the
lateral/ventrolateral PAG in the mid [F(1,20)=29.50, p<.05] and caudal [F(1,20)=50.88,
p<.05] in comparison to handled animals. Moreover, neonatally injured females
displayed significantly increased met-enkephalin immunoreactivity compared to injured
males in the mid [F(1,20)=5.39, p<.05] and caudal [F(1,20)=4.72, p<.05] levels of the
PAG. (F) A significant increase in leu-enkephalin immunoreactivity was noted in CGN
animals in comparison to handled controls in the rostral [F(1,20)=18.46, p<.05], mid
[F(1,20)=14.92, p<.05], and caudal [F(1,20)=13.23, p<.05] levels of the PAG. N=6-8 rats
per group/per sex. * denotes significant main effect of treatment; # denotes significant
main effect of sex.
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Figure 3.6 Continued
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Figure 3.7. Neonatal injury results in decreased MOR-ir in the PAG.
Photomicrograph depicting representative examples of MOR-ir in the
lateral/ventrolateral PAG in adult rats following neonatal treatment; (A) handled; (4X),
(B) handled; (10X), (C) 1% carrageenan; (10X). (D) A significant main effect of
treatment on MOR-ir in the lateral/ventrolateral PAG was noted in the mid
[F(1,20)=26.34, p<.05] and caudal [F(1,20)=31.51, p<.05] levels, where CGN animals
displayed significantly reduced MOR-ir compared to handled animals. N=6-8 rats per
group/per sex. * denotes significant main effect of treatment.
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Figure 3.8. Neonatal inflammatory injury results in a significant decrease in mu
and delta opioid receptor binding in the PAG. A representative example of mu opioid
receptor binding distribution in the PAG in adult rats following neonatal treatment; (A)
handled, (B)1% carrageenan. A representative example of delta opioid receptor binding
distribution on the PAG in adult rats following neonatal treatment; (C) handled, (D) 1%
carrageenan. (E) Neonatally injured (CGN) animals displayed a significant decrease in
MOR-binding in the lateral/ventrolateral subdivision of the rostral [F(1,20)=58.46, p<.05],
mid [F(1,20)=286.50, p<.05], and caudal [F(1,20)=78.89, p<.05] levels of the PAG
compared to handled animals (F) A significant decrease in DOR-binding was noted in
neonatally injured females in comparison to all other groups in the lateral/ventrolateral
region of the mid-PAG [F(1,20)=22.41, p<.05]. A significant main effect of sex was also
observed in this region [F(1,20)=39.74, p<.05]. N=6 rats per group/per sex. * denotes
significant main effect of treatment; # denotes significant main effect of sex.
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4.1 Abstract

Despite mounting evidence on the importance of pain management in preterm infants,
clinical use of analgesics in this population is limited. Our previous studies have shown
that neonatal inflammatory injury results in long-term alterations in adult somatosensory
thresholds, characterized by decreased baseline nociceptive sensitivity, and enhanced
hyperalgesia following a subsequent inflammatory injury. The present studies were
conducted to determine if pre-emptive morphine attenuates these negative
consequences. At P0, pups received an injection of morphine sulfate (MOR) prior to an
intraplantar injection of 1% carrageenan (CGN). Control pups received either saline
(SAL) followed by intraplantar CGN, MOR followed by intraplantar SAL, or SAL followed
by intraplantar SAL. Pre-emptive morphine significantly attenuated neonatal injuryinduced hypoalgesia at P40 and P60. Similarly, morphine pre-treated animals displayed
significantly less hyperalgesia and recovered faster from a subsequent injury compared
to control animals. Neonatal morphine had no significant effect on morphine analgesia
in adulthood. Interestingly, neonatally injured animals that did not receive morphine
displayed a significant rightward shift in the morphine dose response curve in the
absence of peripheral inflammation. Together, these results provide compelling
justification for the use of analgesics prior to the initiation of noxious procedures
performed on neonates.
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4.2 Introduction

Advances in perinatal care have increased the survival of preterm infants in neonatal
intensive care units (NICUs) worldwide. Despite the current knowledge that preterm
infants are responsive to noxious stimuli (Giannakoulopoulos et al., 1999, Smith et al.,
2000, Vanhatalo and van Nieuwenhuizen, 2000), many routine procedures in the NICU
such as repeated heelsticks, circumcisions, endotracheal intubations, and minor
surgeries are performed in the absence of analgesics (Johnston et al., 1997, Porter et
al., 1997, Kahn et al., 1998, Simons et al., 2003). Indeed, recent studies have reported
that neonates experience an average of 14 noxious procedures per day, with fewer than
35% receiving appropriate analgesic therapy (Anand and Craig, 1996, Simons et al.,
2003).
Until the late 1980’s, many in the medical community believed noxious stimuli had no
lasting effects in neonates (Tibboel et al., 2005). It is now well established, however,
that premature infants are indeed highly responsive to noxious stimulation (Andrews
and Fitzgerald, 1999, Smith et al., 2000) and generate developmentally specific and
distinct responses to noxious and non-noxious stimuli (Anand and Carr, 1989,
Giannakoulopoulos et al., 1999). Nociceptive responses to noxious stimulation have
been demonstrated in preterm neonates using an array of physiological, biochemical
and behavioral measures (Franck et al., 2000, McNair et al., 2004). Cortical activation
has also been reported in response to acute noxious stimulation in preterm neonates at
25 weeks, suggesting the potential for higher-level processing of pain (Bartocci et al.,
2006, Slater et al., 2006a, Slater et al., 2006b).
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Accumulating evidence in both human and non-human animal studies indicate that
exposure to invasive procedures during the neonatal period leads to both short and
long-term alterations in nociceptive processing (Grunau et al., 1994a, Anand et al.,
1999, Porter et al., 1999, Anand, 2000b, Ruda et al., 2000, Lidow et al., 2001, Bhutta et
al., 2002, LaPrairie and Murphy, 2007). For example, a higher frequency of painful
invasive procedures in preterm infants has been significantly associated with dampened
pain responses at 32 weeks of age compared to controls (Grunau et al., 2001).
Decreased facial responsiveness to immunization at 4 and 8 months (Oberlander et al.,
2000), and blunted pain sensitivity has also been reported in 18 month old former
preterm neonates compared to full term peers (Grunau et al., 1994a).
Studies in animals have also reported that neonatal injury induces long-term alterations
in basal somatic and visceral sensitivity (Lidow et al., 2001, Wang et al., 2004, LaPrairie
and Murphy, 2007). In particular, animals that received an intraplantar injection of the
inflammatory agent carrageenan on the day of birth display significant hypoalgesia in
both the previously injured and uninjured paws when tested in adulthood (Lidow et al.,
2001, LaPrairie and Murphy, 2007). Similar changes in nociceptive sensitivity have also
been reported using repeated intraplantar 10% formalin injections (Bhutta et al., 2001).
In addition, neonatal inflammatory injury results in enhanced hyperalgesia following a
subsequent injury in adulthood and significantly decreases the rate of recovery (Lidow
et al., 2001, LaPrairie and Murphy, 2007).
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There is wide disagreement among neonatologists regarding the use of opioid
analgesics in the treatment of neonatal pain, and adequate pain management in this
population is hampered by a lack of knowledge regarding analgesic mechanisms in the
immature nervous system. Accumulating data, however, suggests that premature
infants undergoing invasive procedures benefit from the use of opioid analgesics
(Yaster and Deshpande, 1988, Yaster et al., 1989, Fitzgerald, 1991, Anand and Hickey,
1992, Bhat et al., 1992). For example, altered nociceptive responses in former preterm
neonates can be predicted by the number of previous noxious procedures and are
normalized by the early use of morphine as an analgesic (Grunau et al., 2001). In
addition, post-operative morphine analgesia in preterm and full-term infants reduces
behavioral and hormonal stress responses (Farrington et al., 1993, Bouwmeester et al.,
2001, Bouwmeester et al., 2003), and is associated with decreased mortality (Anand et
al., 1987, Anand and Hickey, 1992).
There is significant evidence that opioid analgesics are efficacious in neonatal rodents
(Abbott and Guy, 1995) Few studies, however, have examined whether opioid
analgesics can be used to prevent the long-term consequences of neonatal injury
(Sternberg et al., 2005). Therefore, the present studies were conducted to determine
whether neonatal morphine pre-treatment 1) attenuates neonatal inflammatory injuryinduced mechanical and thermal hypoalgesia in adulthood in male and female rats; 2)
reduces neonatal re-injury induced hyperalgesia observed following adult inflammation
and impacts the rate of recovery; and 3) alters the response to morphine in adulthood.
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4.3 Materials and Methods

Animals
Time-pregnant Sprague-Dawley rats were obtained on the 14th day of gestation (E14)
(Zivic Miller) and housed individually. Animals were maintained on a 12:12h light:dark
cycle, with food and water available ad libitum. On the day of birth (P0), sexing of the
pups was determined by examination of the anogenital distance. Offspring from the
litters were combined on the day of birth, divided up equally, and randomly assigned to
a neonatal treatment condition and dam. All litters were reared identically, weaned at
P21, and housed with same-sex littermates in groups of 2-3. All experiments were
approved by the Georgia State University Animal Care and Use Committee and were
conducted in strict compliance with the guidelines for pain research established by the
International Association for the Study of Pain (IASP).
Early Life Manipulations
On the day of birth (P0), male and female rat pups received an injection of morphine
sulfate (MOR; 2 mg/kg, ip) or saline (SAL) fifteen minutes prior to a unilateral
intraplantar injection of 1% carrageenan (CGN; 5ul) or SAL. This dose of morphine was
chosen based on previous studies (Abbott and Guy, 1995, Nandi et al., 2004). In
preliminary studies, we noted that paw inflammation peaked at five hours postcarrageenan. Therefore, at five hours post-CGN or SAL, a second dose of either MOR
or SAL was administered. This resulted in a total of four groups: MOR+SAL,
MOR+CGN, SAL+CGN, and SAL+SAL. All pups within a litter received the same
neonatal treatment.

82

Maternal Behavior
Maternal behavior was observed for 1 hour following the neonatal manipulation on P0,
and daily at 18:00 hours for 60 minutes from P0-P7. Maternal observations were
conducted by both direct observations (in a manner so as not to disrupt the dam) and by
videotape for later offline analysis. Specific maternal behaviors were recorded including
pup licking/grooming, nursing posture (crouching), hovering over pups, pup retrieval,
nest construction, eating/drinking, exploring, inactive/napping and self-grooming.
Observations were conducted by an individual blind to the neonatal group assignment.
Baseline Nociceptive Behavior
On P40 and P60, baseline paw withdrawal (PWL) and tail flick (TFL) latencies in
response to a noxious thermal and mechanical stimulus were determined. Thermal
testing was conducted using the Paw Thermal Stimulator (UCSD, San Diego,
California). In this test, animals were placed in a clear plastic testing chamber on a
glass surface and allowed to acclimate for a minimum of 30 minutes prior to testing. A
radiant beam of light beneath the glass base was directed at the plantar surface of the
each hindpaw or 1.5 inches from the distal end of the tail, and the withdrawal latency
was electronically measured (in seconds) (Hargreaves et al., 1988). Intact male and
cycling female rats were tested separately. The testing apparatus was thoroughly
cleaned between sessions. The average withdrawal latency of 3 trials was taken; all
trials were separated by a 5-minute inter-trial interval. Application of the thermal
stimulus to either paw or tail was randomly determined. To avoid potential tissue
damage, a 20-second automatic termination of the heat stimulus was imposed if a paw
or tail withdrawal did not occur. Mechanical testing was conducted using a Dynamic
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Plantar Aesthesiometer (Ugo Basile, Italy). Animals were placed in Plexiglas chambers
above a wire mesh, and allowed to acclimate for 30 minutes prior to testing. A metal
probe was directed at the hind paw and the force applied electronically increased until
paw withdrawal occurred. Both time and force were recorded, with an automatic cut off
of 60 seconds and 50 grams, respectively. There was a 5-minute inter-trial interval, and
the average time and force of 3 trials was taken. Body weight and paw diameter for right
and left hind paws were measured prior to baseline testing on P40 and P60.
Nociceptive Behavior Following Re-Inflammation
Following baseline PWL determination at P60, animals received an injection of
Complete Freund’s adjuvant (CFA; 1:1 CFA:saline soln; 200ul; Sigma) into the plantar
surface of the neonatally injured hind paw. CFA was used for re-injury as neonatallyinjured animals may potentially develop antibodies against carrageenan (CGN), thereby
limiting its potency for use as an inflammatory agent. Twenty-four hours following CFAinduced inflammation, paw diameter and PWLs were tested using the Paw Thermal
Stimulator as described above.
Recovery Following Re-Inflammation
Paw diameter and paw withdrawal latencies (right and left paws) were determined in
male and female Sprague-Dawley rats at 7, 14, and 21 days following CFA reinflammation (P60) to determine the impact of morphine pre-treatment on the response
to recovery from a subsequent insult in adulthood.
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Response to Morphine in Adulthood Following Neonatal Morphine Exposure
The effect of neonatal morphine on adult morphine responses was assessed using a
cumulative dosing paradigm. Animals were tested in the absence of inflammation.
Following baseline PWL determination in response to a noxious thermal stimulus,
animals were administered cumulative doses of morphine (1.8, 1.4, 2.4, 2.4, 2.0, and
8.0 mg/kg s.c. injections resulting in quarter log doses of 1.8, 3.2, 5.6, 8.0, 10.0, and
18.0 mg/kg; Sigma, USA) (Morgan et al., 2006). Right PWLs were determined using the
paw thermal stimulator 15 minutes after each injection, followed by the administration of
the subsequent injection 5 minutes later.
Mu Opioid Receptor Western Blot Analysis
Western blot analysis was conducted to confirm that mu opioid receptors are present
supraspinally, spinally, and peripherally in male and female rat pups on the day of birth
(P0). Five hours after birth on P0, rat pups were rapidly decapitated and brain, spinal
cord, and right and left paw tissue was removed and collected on dry ice. Dams were
also rapidly decapitated and maternal blood samples were taken. All tissue and blood
was stored at -80 degrees until processing. Tissue samples were homogenized in
Homogenization Buffer (50mM HEPES pH 7.4, 1mM EDTA, and 0.001% Protease
Inhibitor Cocktail; Sigma USA) on ice. The samples then underwent freeze/thawing
three times on dry ice and 37°C waterbath, respectively, and were subsequently stored
at -80°C. Sample protein concentrations were determined with a BCA Protein Assay Kit
(Pierce) against a BSA standard curve. Next, 20µg of each sample was run on 12%
acrylamide gels, and transferred to PVDF membranes (Bio-Rad). PVDF membranes
were blocked in 5% nonfat dry milk in TTBS (0.1% Tween in 20 mM Tris-HCl; pH 7.5,
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175 mM NaCl) overnight at 4°C. PVDF membranes were washed 3 times with TTBS, 10
min each, then incubated with rabbit anti-MOR (1:50,000; Sigma) and rabbit antiGAPDH (1:300,000; Covance) in 2% nonfat dry milk in TTBS overnight at 4°C.
Membranes were then washed 3 times with TTBS, 10 min each, and incubated with
anti-rabbit HRP conjugated antibodies (1:3000; Cell Signaling) for 1 h at room
temperature. Membranes were then subsequently washed with TTBS 3 times, 10 min
each, and washed in TBS (20 mM Tris-HCl pH 7.5, 175 mM NaCl) for 30 min. Bands
were visualized via chemiluminescence using LumiGLO (KPL). To confirm that the mu
opioid receptor protein observed in the tissue samples was not the result of mu
receptors located on maternal immune cells, western blot analysis was also conducted
on maternal blood samples. Both whole blood and serum were processed as described
for neonatal tissue.
Statistical Analysis
Data are expressed as either raw withdrawal latencies or mean difference scores. All
values are reported as Mean + S.E.M. Data were analyzed for significant main effects of
neonatal treatment and sex using ANOVA and repeated-measures ANOVA was used to
analyze recovery post-CFA data; p< 0.05 was considered statistically significant. A priori
specified post-hoc tests were conducted using the method of Sheffe as warranted to
determine significant mean differences. Where multiple comparisons were made, p
values were adjusted accordingly using the Bonferroni method. Morphine doseresponse curves were plotted and the half maximal effective doses (ED50) were
calculated using percent maximal possible effect (%MPE) data, defined as [(Dose
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mg/kg-baseline PWL)/(20.0-baseline PWL)]100 (GraphPad, Prism). Analysis of variance
was used to compare differences between ED50 values.

4.4 Results

Morphine Pre-Treatment Attenuates the Neonatal Injury-Induced Hypoalgesia in
Adulthood
The present studies were conducted to determine whether neonatal morphine
attenuated the long-term behavioral consequences associated with neonatal
inflammatory injury. Pre-emptive morphine administration significantly attenuated both
thermal (Figure 1) and mechanical (Figure 2) hypoalgesia induced by neonatal
inflammation at P60. Animals that received SAL+CGN displayed significant thermal
hypoalgesia in both the injured and uninjured paws, with females displaying PWLs of
approximately 14 seconds and males 11.5 seconds (p<.05 treatment; p<.05 sex),
versus PWLs of 10 seconds in SAL+SAL animals. In contrast, morphine pre-treated
animals (MOR+CGN) were not significantly different from uninjured controls (p<.05).
Consistent with our previous study (LaPrairie and Murphy, 2007), a significant main
effect of sex on injury-induced thermal hypoalgesia was noted (Figure 1A and 1B).
Morphine pre-treatment also reduced the injury-induced hypoalgesia present in the tail
at P60 (Figure 1C) (P<.05). Furthermore, a significant reduction in the mechanical force
threshold was present in morphine pre-treated animals in both paws in adulthood (P60)
(Figure 2A and 2B) (p<.05). Surprisingly, no sex difference was noted in response to
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noxious mechanical stimulation. Morphine reversal of the injury-induced hypoalgesia
was also observed at P40 (data not shown).
Neonatal Morphine Alters the Response to Re-injury and Recovery
Our previous studies have shown that neonatal injury significantly exacerbates thermal
hyperalgesia following re-inflammation with Complete Freund’s adjuvant (CFA) in
adulthood (LaPrairie and Murphy, 2007). Therefore, the next series of experiments were
conducted to test whether neonatal morphine pre-treatment would attenuate the
response to re-injury and recovery in adult animals. As shown in Figure 3A, neonatal
morphine administration significantly attenuated CFA-induced thermal hyperalgesia at
24 hours compared to control animals (p<.05). At 24 hours post-CFA, PWLs for
SAL+CGN animals were approximately 2 seconds in females (mean difference score,
MDS, of 12 seconds), and approximately 3.5 seconds in males (MDS 8.5 seconds).
Neonatally injured females displayed significantly enhanced thermal hyperalgesia (i.e.
greater MDS) at 24 hours following intraplantar CFA compared to males as previously
reported (p<.05; Figure 3A) (LaPrairie and Murphy, 2007). The rate of recovery was
also significantly reduced in morphine pre-treated compared to control animals (Figure
3B). SAL+CGN animals continued to show signs of hyperalgesia at 14 days (p<.05;
MDS of 1 second in males and 3 seconds in females). In contrast, MS+CGN animals
had completely recovered at this time point (MDS of 0), similar to control animals
(p<.05). Furthermore, a significantly decreased rate of recovery was noted in injured
females compared to injured males; where females displayed greater MDS at 7 and 14
days post-CFA (p<.05).
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Neonatal Morphine Does Not Affect Morphine Analgesia in Adulthood
Exposure to repetitive morphine in neonatal rat pups has been previously associated
with increased TFLs and increased ethanol preference (Bhutta et al., 2001), as well as
down-regulation of the mu opioid receptor in neonatal rat brain (Tempel, 1991).
Therefore, the present study was conducted to determine whether morphine pretreatment prior to intraplantar carrageenan on the day of birth alters the response to
morphine in adulthood. Using a cumulative dosing paradigm, neonatal morphine
administration did not significantly alter morphine’s antinociceptive effects in adulthood
in males or females (Figures 4A and 4B). As summarized in Table 1, morphine pretreated females (MOR+CGN) displayed similar ED50 values as morphine (MOR+SAL)
and saline (SAL+SAL) control females. Interestingly, a significant rightward shift in
ED50 was noted in neonatally injured females (SAL+CGN) that did not receive
morphine (p<.05). Similarly, neonatal morphine in injured males did not alter adult
morphine responses (Figure 4B). Nevertheless, neonatally injured males that received
pre-emptive saline (SAL+CGN) also displayed a significant rightward shift in ED50
compared to MOR+CGN and control males. Finally, a significant main effect of sex was
noted, in that females had significantly higher ED50 values in comparison to males
(p<.05; Table 1), as previously reported (Wang et al., 2006).
Mu Opioid Receptors are Present Peripherally, Spinally, and Supraspinally in Neonatal
Rat Pups
The analgesic effects of morphine are mediated primarily by binding to mu opioid
receptors. Previous studies have reported that mu opioid receptor binding is present in
the spinal cord on P1 (Marsh et al., 1997, Fitzgerald and Beggs, 2001), and that
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systemic morphine does indeed produce analgesia in response to an intraplantar
injection of formalin from postnatal days one through twenty (McLaughlin et al., 1990,
Abbott and Guy, 1995). The presence of brain and peripheral mu opioid receptors,
however, has not been reported for P0 rat pups. Therefore, western blot analysis was
conducted to determine whether mu opioid receptors (MOR) are present centrally and
peripherally on the day of birth. As shown in Figure 5, MOR-like immunoreactivity (LI) is
present on P0 in the brain, spinal cord, and right hindpaw tissue. To control for the
presence of MOR on maternal immune cells, we assessed the presence of MOR-LI on
maternal blood samples taken at 5 hours post parturition. MOR-LI was undetectable in
maternal whole blood or serum (data not shown).
Neonatal Injury Has No Impact on Maternal Care
Previous studies have shown that naturally occurring variations in maternal care can
induce profound and permanent changes in nociceptive responsiveness of offspring
(Johnston and Walker, 2003). Therefore, daily maternal observations were conducted to
determine whether neonatal morphine pre-treatment alters the display of maternal
behavior. There were no significant differences in maternal behavior between morphine
pre-treated and saline pre-treated control animals in the amount of time the dam spent
on/with pups (Figure 6). Similarly, no differences were noted in the amount of time the
dam spent off/without pups or in the amount of time spent licking/grooming pups (Figure
6). This indicates that morphine attenuation of the long-term consequences of neonatal
injury are not due to differences in maternal behavior directed at pharmacologicallytreated versus saline-treated pups.
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4.5 Discussion

Our principal findings are as follows: (1) morphine pre-treatment attenuates neonatal
injury-induced hypoalgesia in adolescent and adult male and female rats; (2) neonatal
morphine reduces inflammatory hyperalgesia following a subsequent inflammation in
adulthood; (3) neonatal morphine administration increases the rate of recovery
following intraplantar CFA; (4) neonatal morphine does not affect morphine analgesia in
adulthood; (5) neonatal injury significantly reduces morphine potency in adulthood.
Pre-emptive Morphine Analgesia Attenuates Long-Term Behavioral Consequences of
Neonatal Inflammatory Injury
The present studies are the first to demonstrate that pre-emptive morphine attenuates
the long-term behavioral consequences associated with neonatal intraplantar
carrageenan in rodents. Morphine administration blocked neonatal injury induced
thermal and mechanical hypoalgesia in both the injured and uninjured paws in
adolescence (P40) and adulthood (P60) in males and females. These results are
consistent with previous studies in rodents that report daily morphine administration
prior to intraplantar formalin during the first week of life significantly reduces the longterm effects of repetitive pain (Abbott and Guy, 1995). Similarly, previous studies in
humans have reported that morphine therapy ameliorates the effects of early repetitive
noxious stimuli in extremely low birth weight infants at 4 months of age (Grunau et al.,
2001). In addition, children who had minor neonatal operations and received preemptive analgesia responded to immunization pain in a similar manner as non-operated
age-matched controls (Peters et al., 2003).
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There is ample evidence that opioid receptors and endogenous opioid peptides appear
early in the development of the CNS, and that the endogenous opioid system is able to
contribute to analgesia during the neonatal period (Anand and Hickey, 1987, Marsh et
al., 1997, Fitzgerald, 2005). Opioids produce potent analgesia by acting directly on
opioid receptors (Anand et al., 2005). The analgesic effects of morphine, in particular,
occur by activation of mu opioid receptors (MOR), which we have shown are present
both centrally and peripherally on P0. In the present study morphine was given
systemically and therefore may be acting on central or peripheral MOR to inhibit
neonatal inflammatory pain.
There is ample evidence that the hypoalgesia observed following neonatal inflammation
may be mediated by a potentiation in descending endogenous opioid tone. Studies
have shown that the functional activity of endogenous opioid systems is enhanced
following noxious inflammatory stimulation (Iadarola et al., 1988, Noguchi et al., 1989).
Furthermore, increased endogenous opioid peptide expression and release in the
periaqueductal gray (PAG) following peripheral inflammation has been reported, and is
associated with decreased nociceptive sensitivity (Williams et al., 1995a). Moreover, we
have previously reported that systemic administration of the opioid antagonist naloxone
HCl results in decreased baseline hypoalgesia in neonatally injured animals (LaPrairie
and Murphy, 2007), suggesting that alterations in opioid tone underlie the observed
hypoalgesia (LaPrairie and Murphy, 2007). Our recent studies suggest that neonatal
injury-induced alterations in opioid tone primarily involve mu and delta opioid receptors
located in the periaqueductal gray (LaPrairie J 2007 SFN poster). These results are
consistent with findings in both former pre-term infants (Buskila et al., 2003, Hermann et
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al., 2006, Goffaux et al., 2008) and rodents treated neonatally with capsaicin (Cervero
and Plenderleith, 1985) that early life trauma may impair the maturation and proper
development of endogenous inhibitory systems in the CNS. In the present study, the
ability of pre-emptive morphine to block the hypoalgesia may indeed occur through
direct modulation of primary afferent drive into the spinal cord, thereby inhibiting the
central relay of inflammatory pain and preventing the subsequent increase in
descending endogenous opioid tone.
We cannot rule out alterations in the HPA axis as a contributing factor to the observed
hypoalgesia. Nociception is one element in a broader context of stress reactivity
(Sternberg and Ridgway, 2003, Grunau et al., 2005), and experimental studies have
shown that exposure to early life stressors can permanently increase nociceptive
thresholds and decrease the behavioral and physiological responses to stress in adult
rodents (Pieretti et al., 1991, Coutinho et al., 2002, Sternberg and Ridgway, 2003). Data
from human preterm infants also suggest that neonatal exposure to noxious stimuli may
alter future pain responses. Ex-preterm infants exposed to four weeks of NICU care
display reduced pain responsiveness following heel lance (Johnston and Stevens,
1996). In addition, pre-term birth is associated with increased salivary cortisol in
response to vaccination at 6 months of age (Peters et al., 2005). Therefore, it is
possible that the effects of morphine on neonatal noxious stimulation in our study are
partly a consequence of modification of the stress response associated with neonatal
inflammation (Stein et al., 1989, Adamson et al., 1991).
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Neonatal Morphine Reduces Inflammatory Hyperalgesia And Increases The Rate Of
Recovery Following Re-injury In Adulthood
In the present study, morphine pre-treatment significantly attenuated CFA- induced
hyperalgesia and increased the rate of recovery, such that both males and females
recovered 7 days faster than non- pre-treated animals. Interestingly, preliminary
anatomical studies in our laboratory suggest that neonatal inflammation results in
increased primary afferent innervation of the dorsal horn reflected by increased
expression of CGRP and substance P immunoreactivity. (LaPrairie JL, Murphy AZ, SfN
abstract, 2005), which may account for our observed hyperalgesia. Our working
hypothesis is that re-inflammation in adulthood results in an enhanced dorsal horn
release of CGRP and/or substance P due to increased primary afferent input. Increased
release of these pro-nociceptive peptides would be predicted to result in an enhanced
hyperalgesic response.
Clinical reports demonstrate that at 32 weeks, preterm infants experience a reduced
rate of recovery to skin breaking procedures (Morison et al., 2003), and exhibit subtle
differences in ability to recover from finger lance at 4 months compared to full term
controls (Oberlander et al., 2000). There are no reports on the impact of pre-emptive
morphine on recovery rates in premature neonates, however, our data suggest that
morphine analgesia may in fact significantly increase the rate of recovery following
procedural pain in NICU infants. Again, neonatal pre-treatment with morphine may
inhibit injury-induced alterations in the descending nociceptive circuit, thereby blocking
the susceptibility of a subsequent injury to produce enhanced hyperalgesia and
increasing the rate of recovery.
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Neonatal Morphine Does Not Affect Morphine Analgesia In Adulthood
Our original hypothesis was that exposure to morphine during neonatal development
may alter opioid receptor number and/or affinity, thereby altering morphine’s
antinociceptive effects in adulthood. This hypothesis was based on previous studies that
report a 60-fold shift in the morphine dose response curve in adult rats that received
repeated neonatal morphine in the absence of pain (Rahman et al., 1998, Bhutta et al.,
2001), and opioid receptor down regulation in the brains of neonatal rats chronically
exposed to morphine (Tempel, 1991). Nevertheless, we show that neonatal morphine
did not affect morphine analgesia in adult animals (i.e. no significant shift in ED50
values). In contrast to the previous reports, however, neonatal morphine administration
was associated with peripheral inflammation and was only provided on P0 in the
present study.
Interestingly, neonatal injury alone resulted in a significant decrease in morphine
potency in both males and females in adulthood. These results have serious clinical
implications. Previous studies have reported that pre-term infants that experience
surgery during the first three months of life have significantly higher peri- and postoperative analgesic requirements in response to surgery in the same or different
dermatome compared to control infants (Bouwmeester et al., 2003, Peters et al., 2005).
Similarly, mice exposed to chronic noxious stimulation display increased tail flick
latencies compared to control animals, and a significant two-fold increase in the ED50
of morphine in response to abdominal constriction (Christie et al., 1982). As noxious
stimulation during the neonatal period leads to increased activation of opioid systems in
a manner analogous to the repeated application of exogenous opiates, these studies
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provide evidence that neonatal injury produces cross-tolerance to the analgesic effects
of morphine thereby decreasing the subsequent effectiveness of morphine (Lett et al.,
2002, Stoller et al., 2002, Stoller et al., 2007). Again interestingly, exposure to morphine
neonatally did not result in a significant shift in ED50 values. Therefore, we believe that
opioid cross tolerance is associated with neonatal injury-induced chronic exposure to
endogenous opioids resulting from a potentiation of the descending inhibitory circuit,
and not a result of exposure to morphine on P0. Alternatively, neonatal stress
associated with maternal separation and repeated handling is also associated with
reduced opioid analgesia (Coutinho et al., 2002, Sternberg and Ridgway, 2003). This
suggests that alterations in opioid analgesia may reflect a combined effect of neonatal
nociceptive experience as well as early life stress, and therefore may involve altered
responsiveness of endogenous analgesia circuits and the hypothalamic-pituitaryadrenal axis (Grunau et al., 2005).

4.6 Chapter 4 Summary

It is well established that the physiological and neurobehavioral systems of preterm
infants are unstable and immature, rendering them more vulnerable to the effects of
invasive procedures. Here we show that pre-emptive morphine ameliorates long-term
effects of neonatal inflammatory injury on adult nociception. Together, our data have
important implications for the analgesic treatment of human infants exposed to invasive
neonatal intensive care.
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4.7 Chapter 4 Figures

Figure 4.1. Morphine attenuates thermal hypoalgesia in adulthood. MS+CGN
animals displayed significantly shorter PWLs compared to SAL+CGN in response to
thermal stimulation applied to the (A) uninjured paw [F(3,73)=61.330,p<.0001]; (B)
injured paw [F(3,73)=80.066,p<.0001]. (C) MS+CGN animals displayed significantly
reduced TFLs compared to SAL+CGN animals [F(3,73)=5.879,p=.0012]. Neonatally
injured females displayed significantly longer PWLs compared to males; uninjured paw
[F(1,73)=8.912,p=.0039] and injured paw [F(1,73)=16.914,p<.0001]. N=5-15 rats per
group/per sex; * significant main effect of treatment; ** significant main effect of sex;
male: ; female: .
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Figure 4.1. Continued
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Figure 4.2. Morphine attenuates mechanical hypoalgesia in adulthood. MS+CGN
displayed significantly reduced force (g) to withdrawal compared to SAL+CGN in
response to mechanical stimulation applied to the (A) uninjured paw
[F(3,40)=50.604,p<.0001] ; (B) injured paw [F(3,40)=56.898,p<.0001]. N=5-15 rats per
group/per sex; * significant main effect of treatment; male: ; female: .
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Figure 4.3. Morphine attenuates the hyperalgesia following re-inflammation and
increases the rate of recovery. MS+CGN animals displayed significantly lower mean
difference scores (MDS) (i.e. reduced hyperalgesia) compared to SAL+CGN animals
(A) 24 hours post-CFA [F(3,36)=22.524,p<.0001]; male: ; female: . (B) At 7, 14 and
21 days post-CFA, SAL+CGN animals displayed a significantly higher MDS (i.e.
reduced rate of recovery) compared to controls [F(6,76)=10.644,p<.0001]. Females
displayed significantly higher MDS (i.e. recovered slower) compared to males
[F(2,76)=3.240,p<.05]. N=5-7 rats per group/per sex; * significant main effect of
treatment; ** significant main effect of sex; male: ; female:  (MS+SAL-Δ; MS+CGN; SAL+CGN-; SAL+SAL-∇).
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Figure 4.4. Neonatal morphine has no effect on morphine analgesia. Neonatal
morphine had no effect on morphine potency in (A) females; or (B) males in adulthood.
Neonatal injury (SAL+CGN) (- - -) produced a significant shift in the morphine doseresponse curve in (A) females [F(3,250)=2.982,p=0.03]; and (B) males
[F(3,208)=2.979,p=0.03] compared to control animals (-----). N=6-13 rats per group/per
sex; MS+CGN-; SAL+SAL-; MS+SAL-; SAL+CGN-.
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Figure 4.5. MOR is present centrally and peripherally on P0. Following western blot
analysis, mu opioid receptor protein was present in the (A) brain; (B) spinal cord; (C)
hind paw on P0.
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Figure 4.6. Neonatal injury has no impact on maternal care. Neonatal injury had no
effect on the duration of time the dam spent (A) on/with her litter F(3,13)=.734,p=.5503,
(B) away from her litter F(3,13)=.393,p=.7600, (C) licking and grooming pups
F(3,13)=1.883,p=.1822. N= 3-6 litters per group.
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Table 4.1. Morphine ED50 Values. A significant effect of sex was present in all four
treatment groups, where males displayed significantly reduced ED50 values compared
to females (p<.05). SAL+CGN males and females displayed significantly greater ED50
values compared to SAL+SAL control animals (p<.05).
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CHAPTER FIVE

Conclusions
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5.1 Conclusions-Overview
Advances in perinatal medical care over the last two decades have substantially
increased the survival of infants born premature (Grunau et al., 2006). As part of this
life-saving care, however, preterm neonates are exposed to multiple invasive
procedures in the neonatal intensive care unit (NICU), including heel lances,
circumcision, endotracheal intubation, and respiratory and gastric suctioning. Growing
clinical and basic science data suggests that exposure to repeated tissue damaging
interventions in neonates with limited analgesic therapy may induce lasting changes in
the CNS and have profound consequences for subsequent nociceptive processing
(Anand, 2000b, Whitfield and Grunau, 2000, Grunau et al., 2005) (Bhutta et al., 2001,
Lidow, 2002, Walker et al., 2003, Ren et al., 2004, Wang et al., 2004). The previous
studies examining the impact of early life noxious insult on adult nociceptive responses,
however, have failed to provide insight into several important factors, including the
existence of potential sex differences in response to the lasting effects of neonatal
noxious stimulation, the biological mechanisms underlying insult-induced deficits in
nociceptive responsiveness, and the attenuation of the long-term consequences of early
noxious stimulation with pre-emptive analgesia. Collectively, the studies included in this
dissertation aimed to address these considerable gaps in the knowledge and contribute
to improved understanding and treatment of the lasting effects of repeated invasive
interventions in premature infants in the NICU.
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5.2 The Lasting Impact of Neonatal Noxious Stimulation

Pain is unique amongst sensory modalities. While olfactory, auditory, and tactile
stimulation are plentiful after birth, the newborn mammalian CNS is rarely exposed to
nociceptive input. During the last two decades, however, this situation has changed
dramatically due to the wide application of intensive care interventions in high-risk
preterm neonates (Lidow, 2002, Fitzgerald, 2004). As the neonatal period is a sensitive
window for experience-induced plasticity due to the ongoing maturation of nociceptive
systems (Fitzgerald and Jennings, 1999), recent evidence from clinical and animal
research studies has reported that noxious stimulation, experienced early in life, can
leave a legacy of altered CNS processing (Grunau et al., 1994a, Anand et al., 1999,
Ruda et al., 2000, Lidow et al., 2001, Bhutta et al., 2002, Ren et al., 2004, LaPrairie and
Murphy, 2007).
While a variety of experimental animal models have been employed to address the
long-term consequences of neonatal noxious stimulation, including colonic irritation (AlChaer et al., 2000), physical tissue damage (Reynolds and Fitzgerald, 1995), sensory
nerve ligation (De Lima et al., 1999), bladder distention (DeBerry et al., 2007) and
recurring noxious stimulation (Anand et al., 1999), many fail to accurately characterize
the common human neonatal experience. During routine medical procedures in the
NICU, preterm infants often experience acute local inflammation that lasts for several
hours to days induced by repeated heel lances, surgical wounds, skin burns, and other
forms of tissue injury (Anand, 1998, Anand, 2000a). Our model of short-lasting neonatal
local inflammation, produced by a single hindpaw injection of carrageenan on the day of
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birth has been designed to simulate the acute, local inflammatory response frequently
experienced by preterm infants in the NICU (LaPrairie and Murphy, 2007).
Neonatal Inflammation-Induced Baseline Hypoalgesia
In our initial studies, we demonstrated that intraplantar inflammation induced on the day
of birth results in significant long-lasting hypoalgesia, as indicated by significantly longer
paw withdrawal latencies in response to a noxious thermal stimulus. Remarkably, this
hypoalgesia was not only present in the neonatally injected hindpaw but also in the
intact contralateral paw. The degree of hypoalgesia produced by our P0 insult is not
trivial; paw withdrawal latencies were more than 40% greater in neonatally inflamed
adults compared to handled and saline control animals and was manifest at both
adolescence (P40) and adulthood (P60). Furthermore, the increase in nociceptive
thresholds following neonatal inflammatory insult was significantly greater in neonatally
injured females compared to injured males (LaPrairie and Murphy, 2007). Our results
parallel previous studies in males that similarly report increased sensory thresholds in
both injected and intact hindpaws, as well as increased tail-flick responses and
enhanced visceral hypoalgesia that persist into maturity in animals that experienced
early life hindpaw inflammation (Lidow et al., 2001, Ren et al., 2004, Wang et al., 2004).
Taken together, these results strongly indicate a neonatal inflammation-induced
globally-driven deficit in nociceptive responsiveness.
Acute Versus Tonic Models of Noxious Insult
The ability of early-life noxious stimulation to induce persistent alterations in nociceptive
processing is clear. Data collected to date, however, suggest that the specific direction
of effects appears to be dependent on the type of insult (acute versus tonic). (Ruda et
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al., 2000, Torsney and Fitzgerald, 2003, Ren et al., 2004). For example, a single
injection of intraplantar carrageenan administered neonatally results in profound
somatic and visceral hypoalgesia in adult rats in response to noxious thermal and
mechanical stimulation (Ren et al., 2004, Wang et al., 2004, LaPrairie and Murphy,
2007). Similar results in somatic nociceptive sensitivity have been reported following
other acute stimuli, including intraplantar formalin, foot shock and neonatal laparotomy
(Shimada et al., 1990, Bhutta et al., 2001, Sternberg et al., 2005). In contrast, chronic
inflammation induced by administration of intraplantar Complete Freund’s adjuvant, as
well as local hindpaw skin wounds, result in persistent hyperalgesia (Fitzgerald et al.,
1989, Ruda et al., 2000). Moreover, repeated intraplantar carrageenan administration
over the first three postnatal weeks results in enhanced nociceptive sensitivity (Lidow et
al., 2001). Thermal hyperalgesia following exposure to repetitive needle pricks, and
lasting visceral hyperalgesia associated with neonatal chronic chemical irritation of the
colon have also been reported (Anand et al., 1999, Al-Chaer et al., 2000).
Interestingly, the aforementioned results suggest that long-term impact of neonatal
noxious insult mirrors the developmental consequences of early life stress. Compelling
evidence in experimental animal models has revealed that perinatal stressful
experiences result in profound and permanent consequences on the behavioral and
neuroendocrine response to stress stimuli in adulthood. Specifically, exposure to a
potent stressor such as repeated maternal separation results in lasting hyperactivation
of the hypothalamic pituitary adrenal (HPA) axis, while brief bouts of handling (i.e. mild
stressor in rodents) during the perinatal period result in a stress hypo-responsive
phenotype (Plotsky and Meaney, 1993, Liu et al., 1997, Caldji et al., 1998). Thus, given
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that the lasting impact of early life stress on the HPA axis is dependent upon the degree
(mild versus severe) of perinatal stress exposure, the type of noxious stimulation (acute
versus tonic), similarly, appears to be critical to the long-term bivalent effects of
neonatal insult on baseline nociceptive thresholds.
Critical Period
The ability of early life experience to alter the organization of the CNS and subsequent
behavior is a major focus of neuroscientific research. Previous research in both human
and non-human animal models suggests that there are periods during nervous system
development within which perturbations have long-lasting, if not permanent
consequences. This is in contrast to the relatively transient effects associated with the
same perturbations at times outside these periods (Bishop, 1982, Rabinowicz et al.,
1996). Our results indicate that there is indeed a critical period for the long-term
consequences of neonatal inflammatory insult on adult sensory thresholds. Animals that
experienced unilateral neonatal hindpaw inflammation on both postnatal days zero and
eight (P0 and P8) displayed a significant decrease in sensitivity to noxious stimuli
(hypoalgesia) in adulthood, compared to animals injured at two weeks of age (P14)
(LaPrairie and Murphy, 2007). Together, these results suggest that the impact of
neonatal inflammation is dependent upon a sensitive period, and that noxious insult
occurring outside of this critical window does not permanently alter thermal sensory
thresholds. Our results are consistent with previous studies that have also reported that
neonatal injury permanently alters visceral and somatic sensory processing, however,
only when induced during the first week of life (Ren et al., 2004, Wang et al., 2004).
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Sex Differences in Response to Neonatal Noxious Stimulation
Given the sizable body of literature that indicates that males and females experience
pain differently (Berkley et al., 1988, Unruh, 1996, Berkley, 1997), it is surprising that
the majority of previous studies examining the impact of neonatal noxious insult have
been conducted exclusively in male rodents (Ruda et al., 2000, Lidow et al., 2001, Ren
et al., 2004). We originally hypothesized that sexually dimorphic organizational
hormones contribute to significant sex differences in response to noxious inflammatory
insult (Weisz and Ward, 1980, Amateau et al., 2004, Balthazart and Ball, 2006, Cornil et
al., 2006), such that elevated central levels of estradiol may act as a “neuroprotectant”
in males, leaving females with low to non-detectable levels of estradiol increasingly
vulnerable to the lasting effects of early life insult (Garcia-Segura et al., 2001, Maggi et
al., 2004, Amantea et al., 2005). To our knowledge, we reported for the first time that
neonatal inflammatory insult was indeed sexually dimorphic, with females displaying
significantly greater basal hypoalgesia in adulthood in comparison to males. The paw
withdrawal latency of females injured with 1% CGN was more than 3 seconds longer in
both the inflamed and intact hindpaws compared to injured males (LaPrairie and
Murphy, 2007). Moreover, we showed that female rats injured at P14, when estradiol
concentrations are comparable in males and females, displayed equivalent levels of
baseline hypoalgesia as injured males. This further suggests that sex differences in the
neonatal neuroendocrine environment contribute to the observed sexually dimorphic
impact of neonatal inflammatory insult (LaPrairie and Murphy, 2007).
Interestingly, however, an observed sex differences in baseline paw withdrawal
latencies was present only at P60 and not at P40 (LaPrairie and Murphy, 2007). This
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observation lends support that activational hormones at puberty may also play a key
role in the sexually dimorphic response to neonatal inflammation. Activational gonadal
hormones have been shown alter the processing of nociceptive information by
influencing endogenous opioid systems (Berglund et al., 1988, Smith et al., 1998), as
well as the activity of other neuromodulators involved in nociceptive processing,
including substance P, gamma-aminobutyric acid (GABA), glutamate, dopamine,
serotonin and norepinephrine. In response to tissue injury, estradiol further modulates
the expression of pro-inflammatory prostaglandins released peripherally (Zhang et al.,
1997), and increases central BDNF expression thereby promoting neuronal survival and
healing (Price et al., 2005). Finally, gonadal hormones have been shown to have a
marked influence on nociceptive and analgesic sensitivity in rodents (Fillingim and
Ness, 2000, Craft et al., 2004).
Future studies directed at manipulating the neonatal neuroendocrine environment,
including masculinizing females or castrating males, as well as pre-pubertal
gonadectomy, are necessary to more specifically implicate gonadal hormones as the
primary factor contributing to the observed sex differences in the impact of neonatal
inflammatory insult. As sex differences in nociceptive behavior likely result from a
confluence of genetic, anatomical, physiological, and hormonal factors (Berkley, 1997),
other key variables may indeed contribute to the sexually dimorphic response to
neonatal inflammatory insult.
Response to a Subsequent Inflammatory Insult in Adulthood
An additional series of experiments was conducted to test whether neonatally injured
animals respond differentially to a subsequent inflammatory insult in adulthood.
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Following baseline behavioral testing at P60, animals received an injection of Complete
Freund’s adjuvant into the plantar surface of either the neonatally injured or previously
intact hindpaw. 24 hours following CFA-induced inflammation, we demonstrated that
male and female rats that experienced neonatal inflammation displayed significantly
greater hyperalgesia than control animals (LaPrairie and Murphy, 2007). Furthermore,
neonatally injured females exhibited significantly greater hyperalgesia in the inflamed
paw than neonatally injured males, and male and female controls. This effect was
observed in both the neonatally injured and uninjured paws, and is consistent with
previous studies reporting long-lasting sensitization of afferent neurons and
hyperalgesia following neonatal insult (Reynolds and Fitzgerald, 1995, Anand et al.,
1999, Al-Chaer et al., 2000).
This increased hyperalgesia following re-inflammation in adulthood may appear
disparate with the observed basal hypoalgesia. Our preliminary anatomical studies,
however, suggest that neonatal inflammatory insult results in alterations in primary
afferent innervation of the dorsal horn (LaPrairie and Murphy, 2005), which may account
for our observed hyperalgesia. In particular, neonatal inflammatory insult increases
primary afferent innervation in the L3-L5 spinal cord, as reflected by increased
expression of both CGRP and substance P immunoreactivity. Parallel changes were not
observed in CGRP expression in the thoracic spinal cord of injured animals. Similar
findings of an increase in substance P levels in laminae I and II of the dorsal horn have
been reported following chronic inflammation in rodents (Honor et al., 1999). As both
CGRP and substance P are pro-nociceptive, enhanced dorsal horn release of these
peptides due to increased primary afferent input would be associated with an enhanced
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response to noxious stimulation, and may provide the biological basis for the observed
increased hyperalgesia following intraplantar CFA in adulthood.
Our dual findings of baseline hypoalgesia and enhanced hyperalgesia following a
subsequent insult are surprisingly consistent with previous reports in former premature
children. Grunau and colleagues found that ex-preterm neonates are rated by parents
as less reactive to everyday bumps and scrapes, while concurrently these children rate
medical procedural pain as more intense (Grunau et al., 1994a, Grunau et al., 1998a).
Similarly, adolescents with prior NICU experience display an increased threshold for
acute thermal stimuli (i.e. decreased sensitivity), but enhanced perceptual sensitization
to a prolonged heat stimulus (i.e. hyper-sensitivity) (Hermann et al., 2006).

5.3 Increased Endogenous Opioid Tone: A Potential Mechanism for the Neonatal
Inflammation-Induced Deficits in Nociceptive Responsiveness

A substantial amount of research within the last decade has focused on the impact of
neonatal noxious stimulation on developing nociceptive circuitry and subsequent pain
processing. The mechanisms underlying the long-term deficits associated with neonatal
noxious insult, however, have not been elucidated. Our laboratory has demonstrated
that mild neonatal intraplantar inflammation results in significant long-term hypoalgesia
that is present in both the previously injured and uninjured paws- indicating global,
injury-induced alterations in basal nociceptive sensitivity. Therefore, behavioral and
anatomical studies were conducted to test the hypothesis that our observed
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hypoalgesia is mediated by an increase in endogenous opioid tone in descending
inhibitory pathways.
Physiological Impact
In our initial studies, we found that administration of the broad-spectrum opioid
antagonist naloxone HCl completely reversed the hypoalgesia induced by neonatal
inflammatory injury, suggesting an increase in tonic endogenous opioid tone. Evidence
that early life trauma can shape the maturation of descending inhibitory circuits has
previously been reported in both human and non-human animal studies. Preterm infants
exposed to numerous interventions in the NICU display significantly altered endogenous
inhibitory responses to noxious thermal stimulation, as well as heightened cardiac
reactivity compared to both term-born and premature infants exposed to few noxious
procedures (Goffaux et al., 2008). A deficit in descending inhibitory systems has also
been implicated in several chronic pain conditions, including fibromyalgia (Henriksson,
1994, Julien et al., 2005), irritable bowel syndrome (Wilder-Smith et al., 2004), and
tension-type headache (Pielsticker et al., 2005). Lastly, tonic descending inhibition of
dorsal horn neurons is substantially decreased in adult rats treated at birth with
capsaicin, a neurotoxin that acts at unmyelinated c-fibers (Cervero and Plenderleith,
1985). Therefore, an increase in dorsal horn c-fiber innervation, as evidenced in adult
animals following neonatal intraplanar carrageenan (LaPrairie and Murphy, 2005), may
indeed result in a compensatory up-regulation of tonic endogenous opioid inhibition.
In subsequent experiments, we investigated the involvement of central versus
peripheral opioid receptors in the mediation of neonatal inflammation-induced increase
in opioid tone. Administration of naloxone methiodide, a peripherally-acting opioid
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antagonist (Ji et al., 2006), had no effect on the behavioral deficits in nociception
associated with early inflammatory insult. In contrast, intracerebroventricular
administration of naloxone HCl significantly attenuated the neonatal injury-induced
hypoalgesia, implicating central not peripheral, endogenous opioidergic pathways as
mediating the observed hypoalgesia in neonatally injured animals.
There is considerable evidence that the functional activity of central endogenous opioid
systems is enhanced following noxious stimulation. In spinal dorsal horn neurons, prodynorphin and pro-enkephalin biosynthesis is up-regulated in response to carrageenan-,
formalin- and CFA-induced inflammation (Iadarola et al., 1988, Noguchi et al., 1989).
Inflammation–induced changes in endogenous opioid peptide expression and release
have also been reported at several supraspinal sites, including the periaqueductal gray
(PAG) (Williams et al., 1995a). Noxious stimulation-induced changes in opioid peptide
expression are also paralleled by an increase in mRNA expression (Iadarola et al.,
1988). While these studies were conducted in adult males, it still provides supporting
evidence that a peripheral insult can induce changes in central opioid peptide
expression.
The PAG has been shown to a principal mediator of descending anti-nociceptive
mechanisms (Budai and Fields, 1998). In addition, the PAG is rich in nerve terminals
and fibers containing endogenous opioids (Reichling et al., 1988) and opioid receptors
are localized throughout the rostral-caudal axis of the PAG (Duncan and Murphy, 2005).
Therefore, we hypothesized that neonatally injury-induced alterations in endogenous
opioid tone are mediated within the PAG. Site-specific administration of naloxone HCl
into the ventrolateral PAG significantly reduced the basal hypoalgesia associated with
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neonatal inflammation in both male and female rats. These results suggest that
opioidergic systems are persistently and functionally altered in the PAG in response to
neonatal inflammation, although the involvement of additional loci including the RVM
and spinal cord cannot be ruled out (Mansour et al., 1995a, Mansour et al., 1995b,
Budai and Fields, 1998).
We next examined the role of specific opioid receptor subtypes in the PAG. Intra-PAG
administration of the highly selective mu and delta opioid receptor antagonists, CTOP
and naltrindole, attenuated the observed hypoalgesia in neonatally injured animals,
albeit to differing degrees in males and females. In contrast, the kappa receptor
antagonist, Nor-BNI, did not reduce the hypoalgesia in neonatally-injured animals,
indicating that mu and delta opioid receptor systems, but not kappa, contribute to
alterations in endogenous opioid tone in the PAG induced by neonatal inflammation.
Anatomical Impact
Our next series of experiments was conducted to determine whether neonatal
inflammatory insult induced anatomical alterations in opioidergic systems within the
PAG. As site-specific antagonist injections indicated injury-induced alterations in mu
opioidergic systems, immunohistochemical studies were conducted to examine the
expression of beta-endorphin in the PAG. A significant increase in beta-endorphin
peptide expression was noted in neonatally injured animals; this increase was restricted
to mid and caudal levels of the lateral/ventrolateral PAG. Beta-endorphin was mainly
concentrated in cell bodies of the hypothalamic arcuate nucleus with neuronal
innervation of the PAG, as previously reported (Mansour et al., 1995a, Mansour et al.,
1995b, Millan, 2002). According to previous studies, beta-endorphin containing
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pathways projecting from the arcuate nucleus to the PAG moderate nociception via mu
opioid receptors in response to tissue inflammation (Porro et al., 1988, Facchinetti et al.,
1992).
Met- and leu-enkephalin via action at delta-opioid receptors exert an important role in
contributing to the expression of descending inhibition in the dorsal horn. The
significance of supraspinal populations of enkephalin-containing neurons in the
response to noxious stimuli and their mediation of nociception has been widely
discussed (Basbaum and Fields, 1978, Millan, 1982, Millan, 2002). We demonstrated
that neonatal inflammation results in a significant elevation in enkephalin
immunoreactivity in the lateral/ventrolateral region of the mid and caudal PAG.
Immunohistochemical and autoradiographical studies also revealed a significant
decrease in mu and delta opioid receptor expression in the PAG in neonatally injured
animals compared to controls. Specifically, neonatally injured animals displayed a
significant reduction in mu opioid receptor (MOR) immunoreactivity and binding affinity
in the lateral/ventrolateral PAG. Injury-induced alterations were mainly restricted to the
mid and caudal levels of the PAG, whereas the rostral PAG appeared mostly
unaffected. The mid and caudal levels of the PAG have dense projections to the RVM
and are preferentially involved in the descending modulation of pain (Beitz, 1982, Beitz
et al., 1983). Similarly, neonatal injury also resulted in a significant decrease in delta
opioid receptor binding in the lateral/ventrolateral mid-PAG. Thus, neonatal
inflammatory insult induces a central up-regulation of endogenous opioid ligands that is
paralleled by a compensatory down-regulation of cognate opioid receptors in the PAG.
Similar findings have been reported in rodent models in response to chronic arthritis
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(Morris, 1993, Spetea et al., 2002). Future investigations directed at establishing a
developmental time-course of the neonatal insult-induced anatomical alterations, as well
as radioimmunoassay studies verifying increased basal endogenous opioid levels in the
PAG are necessary to provide further insight into the lasting effects of early
inflammation on descending inhibitory circuits.
The data presented herein constitute a compelling case that early noxious insult
produces significant long-term alterations in endogenous descending inhibitory
mechanisms, thereby profoundly impacting nociceptive responsiveness. Our laboratory
has preliminary evidence to suggest that neonatal intraplantar carrageenan induces a
substantial increase in primary afferent innervation of the dorsal horn of the lumbar
spinal cord. Our working hypothesis is that the CNS responds to neonatal injury with a
compensatory increase in endogenous opioid tone- characterized by a significant
increase in beta-endorphin and met/leu-enkephalin in an effort to mask the sensitization
of dorsal horn cells. This increased regulation of opioid peptide results in a parallel
decrease in mu- and delta- opioid receptor expression in the PAG, probably due to
receptor internalization or ligand-induced changes in receptor availability similar to that
observed following long-term drug use (Zhang et al., 2002, Haberstock-Debic et al.,
2003, Tong et al., 2003). This increase in opioid tone contributes to the observed
hypoalgesia at baseline testing. However, in the presence of a subsequent major
noxious insult, neonatally injured animals display enhanced hyperalgesia. This may be
the result of either increased release of pro-nociceptive peptides (i.e. CGRP and
substance P) from primary afferent neurons or reduced strength dynamic inhibition due

120

to a ceiling effect following the chronic elevation of tonic inhibitory mechanisms (Figure
5.1).

5.4 Neonatal Morphine Blocks the Lasting Consequences of Neonatal
Inflammatory Insult

The survival rates of preterm infants have increased substantially around the world due
to advances in NICU care. Despite the current knowledge that preterm infants are
responsive to noxious stimuli (Giannakoulopoulos et al., 1999, Smith et al., 2000,
Vanhatalo and van Nieuwenhuizen, 2000), many routine procedures in the NICU are
performed in the absence of analgesics (Johnston et al., 1997, Porter et al., 1997, Kahn
et al., 1998, Simons et al., 2003). Nevertheless, accumulating data suggests that
premature infants undergoing invasive procedures benefit from the use of opioid
analgesics (Yaster and Deshpande, 1988, Yaster et al., 1989, Fitzgerald, 1991, Anand
and Hickey, 1992, Bhat et al., 1992). Therefore in our final series of experiments, we
examined whether administration of pre-emptive morphine would attenuate the longterm consequences associated with neonatal inflammatory insult, and given the recent
reports that morphine produces a greater degree of analgesia in males than females
(Loyd et al., 1997), we also tested whether morphine was equally efficacious in both
sexes.
Morphine administration blocked neonatal injury induced thermal and mechanical
hypoalgesia in both the injured and uninjured paws in adolescence (P40) and adulthood
(P60). Morphine attenuation of the injury-induced hypoalgesia was comparable in males
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and females. These results are consistent with previous studies in rodents that report
daily morphine administration prior to intraplantar formalin during the first week of life
significantly reduces the long-term effects of repetitive pain (Abbott and Guy, 1995).
Previous studies in humans have also reported that morphine therapy ameliorates the
effects of early repetitive noxious stimuli in extremely low birth weight infants at 4
months of age (Grunau et al., 2001). Similarly, children who had minor neonatal
operations and received pre-emptive analgesia responded to immunization pain in a
similar manner as non-operated age-matched controls (Peters et al., 2003).
In the present study, the ability of pre-emptive morphine to block the hypoalgesia may
indeed occur through direct modulation of primary afferent drive into the spinal cord,
thereby inhibiting the central relay of inflammatory pain and preventing the subsequent
increase in descending endogenous opioid tone. The effects of morphine in our study
may partly be a consequence of modification of the inflammatory response and/or the
stress response to neonatal inflammatory insult (Stein et al., 1989, Adamson et al.,
1991).
Neonatal morphine also significantly attenuated CFA- induced hyperalgesia and
increased the rate of recovery, such that both males and females recovered 7 days
faster than saline treated injured controls. As previously stated, increased primary
afferent innervation of the spinal cord dorsal horn following neonatal inflammatory insult
may account for our observed hyperalgesia in adulthood (LaPrairie and Murphy, 2005).
Administration of morphine at the time of injury would be expected to inhibit this
increase in primary afferent input, thereby preventing the entire cascade of behavioral,
physiological and anatomical deficits associated with neonatal inflammation. In regard
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to recovery, clinical reports demonstrate that at 32 weeks of age, preterm infants
experience a reduced rate of recovery to skin breaking procedures (Morison et al.,
2003), and exhibit subtle differences in ability to recover from finger lance at 4 months
compared to full term controls (Oberlander et al., 2000). There are no reports on the
impact of pre-emptive morphine on recovery rates in premature neonates, however, our
data suggest that morphine analgesia may in fact significantly increase the rate of
recovery following procedural pain in NICU infants.
Initially, we hypothesized that exposure to morphine during neonatal development may
alter opioid receptor number and/or affinity, thereby altering morphine’s antinociceptive
effects in adulthood. This hypothesis was based on previous studies that report a 60fold shift in the morphine dose response curve in adult rats that received repeated
neonatal morphine in the absence of pain (Rahman et al., 1998, Bhutta et al., 2001).
Opioid receptor down regulation in the brains of neonatal rats chronically exposed to
morphine has also been reported (Tempel, 1991). However in our studies using a
cumulative dosing paradigm, we demonstrated that neonatal morphine administration
did not significantly alter morphine’s antinociceptive effects in adulthood in males or
females (i.e. no significant shift in ED50 values). Interestingly, a significant rightward
shift in ED50 was noted in neonatally injured animals that did not receive neonatal
morphine.
These results have serious clinical implications. Previous studies have reported that
pre-term infants that experience surgery during the first three months of life have
significantly higher peri- and post-operative analgesic requirements in response to
surgery in the same or different dermatome compared to control infants (Bouwmeester
123

et al., 2003, Peters et al., 2005). Similarly, mice exposed to chronic noxious stimulation
display increased tail flick latencies compared to control animals, and a significant twofold increase in the ED50 of morphine in response to abdominal constriction (Christie et
al., 1982). As noxious stimulation during the neonatal period leads to increased
activation of opioid systems in a manner analogous to the repeated application of
exogenous opiates, these studies suggest that neonatal injury produces cross-tolerance
to the analgesic effects of morphine thereby decreasing the subsequent effectiveness of
morphine (Lett et al., 2002, Stoller et al., 2002, Stoller et al., 2007). Again interestingly,
exposure to morphine neonatally did not result in a significant shift in ED50 values.
Therefore, we believe that opioid cross tolerance is associated with neonatal injuryinduced chronic exposure to endogenous opioids resulting from a potentiation of the
descending inhibitory circuit, and not a result of exposure to morphine on P0.
Alternatively, neonatal stress associated with maternal separation and repeated
handling has also been suggested to reduced opioid analgesia (Coutinho et al., 2002,
Sternberg and Ridgway, 2003). This suggests that alterations in opioid analgesia may
reflect a combined effect of neonatal nociceptive experience as well as early life stress,
and may involve altered responsiveness of endogenous analgesia circuits as well as the
hypothalamic-pituitary-adrenal axis (Grunau et al., 2005).
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5.5 Evolutionary Perspective

Critical Period
A critical period is a developmental time point in which heightened brain plasticity allows
neural circuits to be shaped by experience (Hensch et al., 2004). We have
demonstrated that the lasting consequences of neonatal noxious stimulation are critical
period dependent-where animals injured at P0 and P8, but not P14 display significant
hypoalgesia in adulthood (LaPrairie and Murphy, 2007). Our laboratory and others have
demonstrated that a mild noxious insult during this critical period results in decreased
nociceptive sensitivity in adulthood (LaPrairie and Murphy, 2007, Ren et al., 2006,
Bhutta et al., 2004), whereas a major noxious insult results in long-lasting cutaneous
hypersensitivity (Fitzgerald et al., 1989, Ruda et al., 2000), suggesting that the direction
of the response is mediated by the intensity of the noxious stimulus.
From an evolutionary prospective, natural selection may have shaped offspring to
respond to subtle variations in their early environments during developmental critical
periods as a forecast of the environmental conditions they will ultimately face in
adulthood (Badyaev et al., 2005, Crespi et al., 2005). This phenotypic plasticity permits
organisms to “mold” their form to prevailing circumstances during early development,
ultimately leading to stable variations in phenotype that serve to increase the capacity of
the offspring throughout its lifetime (Fishet al., 2004, Meaney et al., 2007). For example
in rats, naturally occurring variations in the quality of mother-pup interactions program
the development of individual differences in the behavioral and endocrine response to
stress through epigenetic modification of the glucocorticoid receptor gene (Zhang et al.,
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2004, Meaney et al., 2005). Similarly, water fleas (Daphnia) form helmet-like neck
growths and tail spines in response to chemosignals from aquatic predators, thereby
reducing the likelihood of capture and successful ingestion (Agrawal et al., 1999).
Exposure of females to predator chemosignals is sufficient to alter the morphology (i.e.
significantly larger helmets) of predator chemosignal-naïve offspring (Agrawal et al.,
1999, Tollrian et al., 1995). Therefore, variations in early environmental exposure to
noxious stimulation may alter the development of nociceptive systems during an early
postnatal critical period, which lead to sustained variations in nociceptive
responsiveness (i.e. hyper versus hypo). Under conditions of increased adversity and
nociceptive demand (i.e. high threat and predation, prevalent intra-group competition), it
would be advantageous for an animal to enhance its behavioral and physiological
responsiveness to nociceptive stimulation. These responses would be essential under
the increased demands of repeated exposure to noxious stimuli that are potentially life
threatening. Decreased nociceptive reactivity resulting in reduced responsiveness to
“irrelevant” or “background” stimuli, would increase the capacity of offspring under
favorable environmental conditions with few threats of endangerment.
While lasting alterations in gene expression induced by environmental factors during
critical periods have been demonstrated in a wide variety of species (Reik et al., 2007,
Chandler et al., 2007, Casadesus et al., 2006), a critical period for the effects of
neonatal noxious stimulation on developing nociceptive circuitry has only been
demonstrated in rats (LaPrairie and Murphy, 2007, Ren et al., 2004). One may
speculate that these results would indeed extend to other species that may experience
a noxious insult during a critical period of postnatal plasticity in nociceptive circuits (i.e.
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rat, mouse, zebra finch). In contrast, these effects would be unlikely in species where
development of nociceptive circuitry primarily occurs during gestation (i.e. guinea pigs,
sheep, rhesus macaques), when the likelihood of noxious insult is low. In summary,
critical periods for sensory systems may be selected for evolutionarily to program
advantages in the developing neural circuits that adaptively match the environments the
neonates will ultimately face in adulthood, whereby differing degrees of environmental
demand require sustained differences in nociceptive reactivity dependent upon noxious
stimulation during early life.
Sex Differences
Our studies have demonstrated that an inflammatory insult induced on the day of birth
results in long-lasting hypoalgesia, as indicated by significantly longer paw withdrawal
latencies in response to noxious thermal stimulation. Increased sensory thresholds (i.e.
decreased nociceptive sensitivity) are present in the both neonatally injured hindpaw as
well as the intact contralateral paw in adulthood, and are significantly greater in
neonatally injured females compared to injured males (LaPrairie and Murphy, 2007).
ADAPTIVE EXPLANATION: A major contribution of Charles Darwin was the
observation that evolutionary pressures often differ for males and females, and that
many of these differences are centered around the dynamics of reproduction (Darwin,
1871). Sexually selective pressures typically result in male-male competition for social
status, resources, or territory in an effort to attract mates, and female choice of mating
partners (Andersson et al., 1994). Although the dynamics of male intrasex competition
can vary across species, one common result is the evolution of physical and behavioral
sex differences. Male-male competition and female mate choice are most evident in
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species in which males devote most of their reproductive energies to attracting mates
and female provide the majority of parental care (Trivers et al., 1972), characteristics
observed in most mammalian species (Clutton-Brock et al., 1991). Therefore, sex
differences in nociceptive responsiveness following early noxious insult may have
evolved in response to the differing reproductive demands of adult males and females.
For example in an environment with few threats of endangerment, significantly reduced
nociceptive responsiveness would be highly advantageous in females, as their primary
role involves the successfully care of offspring. In males, this degree of reduced
nociceptive reactivity would be disadvantageous. A moderate degree of reduced
behavioral responsiveness may be selected for in males, whereby still allowing for
increased vigilance in noxious bouts of intrasex competition for resources. Sex
differences in response to neonatal noxious insult would likely be evident in all species
that demonstrate characteristic sexually dimorphic reproductive roles.
NONADAPTIVE EXPLANATION (Biological Spandrel): Alternatively, the observed sex
differences following neonatal noxious insult may be similar to Stephen J. Gould’s
Spandrels of San Marco-a byproduct of the sexual differentiation process (Gould et al.,
1979). “Spandrel” is a term used to describe a phenotypic characteristic that is
considered to have developed during evolution as a side effect of a true adaptation
(Gould et al., 1979, Gould et al., 1997). Sexual differentiation of the rat brain occurs
from E18-P10 (MacLusky et al., 1981, Arnold et al., 1984), whereby males experience a
significant surge of testicular testosterone that is centrally aromatized to estradiol,
ultimately resulting in masculinization of the nervous system (Amateu et al., 2004, Cornil
et al., 2006). During this period of sexual differentiation, steroids affect a wide variety of
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cellular mechanisms, including neurogenesis, cell death, cell migration, synapse
formation and synapse elimination throughout the CNS (Cooke et al., 1998). Therefore,
sexual differentiation of the nervous system may be adaptive, whereas its impact on
nociceptive circuitry and development of a sexually dimorphic response to neonatal
noxious insult may be a secondary consequence, albeit with a subsequent exaptive
utility. While this physiological adaptation may not be heritable, the capacity to develop
the adaptation presumably is. Our laboratory is the first to demonstrate a sex difference
in response to neonatal injury (LaPrairie and Murphy, 2007), and therefore, it is
unknown whether these observations would extend to other species. One may
speculate that this effect would be present in species where noxious insult and sexual
differentiation of the nervous system could theoretically overlap (i.e. late prenatal or
postnatal sexual differentiation).

5.6 Final Remarks

Although research into the long-term consequences of noxious stimulation during the
neonatal period have spanned over two decades, our understanding of neonatal pain is
literally still in its infancy. The studies in this dissertation aimed to fill some of the critical
gaps of knowledge in this field. First, we established that exposure to a single neonatal
inflammatory insult is associated with a lasting decrease in basal nociceptive sensitivity
and enhanced sensitivity following a subsequent inflammatory injury that is significantly
exacerbated in females. The clear presence of a sex difference in the response to early
insult may indeed contribute to the higher prevalence, severity and duration of pain
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syndromes in women than men. Second, we were the first to demonstrate that the
profound elevation of nociceptive thresholds following neonatal inflammation is
mediated by an experience-induced facilitated activation of descending nociceptive
pathways, characterized by dynamic physiological and anatomical modification and
modulation of opioidergic systems in the PAG. Finally, we showed that pre-emptive
morphine ameliorates the long-term effects of neonatal inflammatory injury on adult
nociception, which provides compelling justification for the use of analgesics prior to the
initiation of noxious procedures performed on neonates. Collectively, these studies
present valuable information about the long-term consequences of neonatal noxious
stimulation in males and females, which may ultimately lead to improved understanding
and treatment of the lasting effects of repeated invasive interventions in premature
infants in the NICU.
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5.7 Chapter 5 Figures

Figure 5.1 The Lasting Impact of Neonatal Inflammatory Insult: A Summary.
(A) Intraplantar carrageenan (CGN) on the day of birth (P0) results in (B: left-handled;
right-1% CGN) a lasting increase in primary afferent innervation of the dorsal horn of the
lumbar spinal cord, ultimately leading to (C) an increase in endogenous opioid tone
which is characterized by (D: top left-met enkephalin handled; top right-met enkephalin
1% CGN; bottom right-beta endorphin 1% CGN; bottom left-beta endorphin handled) a
significant increase in enkephalin and beta endorphin immunoreactivity and (E: top leftMOR handled; top right-MOR 1% CGN; bottom right-DOR 1% CGN; bottom left-DOR
handled) a significant decrease in mu and delta opioid receptor binding in the PAG. This
increase in opioid tone contributes to the (F) observed hypoalgesia at baseline testing.
(G) In the presence of a subsequent major noxious insult in adulthood, (H: left-handled;
right-1% CGN) neonatally injured animals have increased release of pro-nociceptive
peptides (i.e. CGRP and substance P) compared to handled animals, resulting in (I)
enhanced hyperalgesia following intraplantar CFA.
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